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 Untersuchung der Expression von Nitric Oxid Synthase (NOS) Genen in in vitro 
erzeugten Rinderembryonen 
Diese Untersuchung wurde durchgeführt, um die Rolle von NO in bovinen Oozyten und 
während der Entwicklung der Embryonen im präimplantativen Stadium zu untersuchen, 
das temporale Expressionsmuster der NOS Gene in den präimplantativen 
Entwicklungsstadien zu identifizieren und die Protein Produkte von iNOS und eNOS 
während dieser Zeit zu finden und lokalisieren. Kumulus-Oozyten Komplexe und 
Einzell- Embryonen wurden in Maturations- und/oder Kulturmedium ohne/mit 
unterschiedlichen Mengen von L-NAME, einem NO Inhibitor, inkubiert. Nach der 
Inkubation wurden die Blastozystenrate und ebenfalls die Teilungsrate festgestellt. Es 
wurden keine signifikanten Effekte des Inhibitors bei der Maturation der Oozyten mit 
L-NAME im Medium festgestellt. Bei der Kultivierung unterdrückt L-NAME die 
Embryoentwicklung bei 10 mM signifikant (p≤0,05) verglichen mit der Kontrollgruppe 
(Blastozystenraten von 1 ± 2 % bei 10 mM verglichen mit 15 ± 10 % bei 0 mM). Dieser 
Effekt wurde verkleinert, wenn L-NAME auf 0,1 oder 1 mM reduziert wurde. Ähnliche 
Ergebnisse wurden nach der Zugabe des Inhibitors in Maturations- und Kulturmedium 
beobachtet. Die Zugabe des Inhibitors hatte keinen Effekt auf die Teilungsrate weder 
bei der Maturation, Kultur oder beiden. Bei der Maturation wurde eine Teilungsrate von 
71 ± 11 %, 63 ± 13 % bis 63 ± 11 % bei jeweils 0, 1 und 10 mM L-NAME  beobachtet. 
Mit der Real-Time RT PCR Technik wurde festgestellt, dass die iNOS und eNOS Gene 
in Oozyten, 2-Zell und 4-Zell Embryonen gut exprimiert waren, jedoch weniger stark in 
anderen Stadien mit der Ausnahme von iNOS im Blastozystenstadium. Das 
Expressionsniveau war in maturierten Oozyten verglichen zu immaturen Oozyten 
niedrig. nNOS war in Oozyten, 4-Zelenl und Morulaes Embryonen exprimiert. NOS 
Proteine wurden im Cytoplasma der Oozyten bis zu den Blastozystenstadien mit einer 
schwachen Färbung im Zellkern lokalisiert.  
Unsere Ergebnisse zeigen zum ersten Mal alle drei NOS Expressionsprofile in 
preimplantativen Rinderembryonen, was bestätigt, dass NO aus drei verschiedenen 
Isoformen synthetisiert wird, welche die bovine präimplantative Entwicklung 
beeinflussen.  
 
 
 
 
 Nitric oxide synthase (NOS) genes expression in cattle in vitro produced embryos  
 
This study was conducted to determine whether NOS-NO affects oocytes meiotic 
maturation and embryo development in vitro in bovine, to profile the temporal 
expression pattern of NOS genes, then to detect and localize the protein products of 
iNOS and eNOS in preimplantation developmental stages. Cumulus-oocyte complexes 
and one-cell embryo were incubated in maturation or/and culture media without or with 
different doses of L-NAME, an inhibitor of NO. End point was blastocyst rate but 
cleavage rate was examined also. No significant effect of the inhibitor was obtained 
when oocytes were matured in presence of L-NAME as indicated by a blastocyst rate of 
28 ± 14 %, 19 ± 15 % and 22 ± 11 % at 0, 1 and 10 mM respectively. However, high 
levels of arrested blastocyst rates were indicative of an impairment of normal 
development. At culture, L-NAME inhibited embryo development at 10 mM, 
significantly (p ≤ 0.05) compare to control group (blastocyst rates of 1 ± 2 % at 10 mM 
against 15 ± 10 % at 0 mM). The inhibitory effect was reduced when L-NAME was 
decreased to 0.1 or 1 mM. Similar result was observed after application of the inhibitor 
in maturation and culture media. The application of the inhibitor had no effect on the 
cleavage rates either at maturation, culture or both at any concentration compared to the 
control group. In maturation, 71 ± 11 %, 63 ± 13 % and 63 ± 11 % cleavage rates  have 
been obtained at 0, 1 and 10 mM L-NAME respectively. Using real-time RT PCR, the 
iNOS and eNOS genes were found well expressed in oocytes, 2C and 4C embryos but 
were far less prevalent in other developmental stages, except iNOS at blastocyst stage. 
Their expression levels were low in mature oocytes compare to immature oocytes. The 
absence of quantifiable eNOS or iNOS at 8C and morulae was in contradiction to the 
qualitative identification. Neuronal NOS mRNA was measurable only in immature 
oocytes, 4C and morulae stages. NOS proteins detected by immunohistochemistry were 
localized in cytoplasm of oocytes to blastocyst stages with a weak staining in the nuclei. 
In germinal vesicle-stage oocytes, the immunoreactivity was localized in the ooplasm 
but after GVBD, it mostly accumulated around the condensed chromosomes. Our 
results show for the first time all three NOS profiles, confirming that NO is synthesized 
from different isoforms to ensure bovine preimplantation development, and also their 
proteins are detectable by using immunofluorescence staining.
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Introduction   1
1 Introduction 
 
In vitro production systems are required to produce large numbers of viable embryos for 
biotechnical manipulations or commercial purposes in farm animals. The integration of 
in vitro produced embryos into production systems as a means of producing inexpensive 
embryos or salvaging embryos from injured, old, or infertile cows that no longer 
respond to super-ovulation is dependent on having viable embryos at the time of 
transfer (Kawarsky et al. 1999). During preimplantation development, 15-50% of the 
embryos die as a result of factors involving genes that control both rate of development 
and degree of fragmentation (Warner et al. 1998). The rapid expansion of in vitro 
production has not been without problems, mostly on embryo quality and viability 
(abortion, neonatal mortality) where nitric oxide (NO) is involved in the impairment of 
normal development. Nitric oxide is produced from L-arginine by a family of enzymes, 
the nitric oxide synthases (NOS). Three main distinct genes encoding mammalian NOS 
isoenzymes have been identified. Constitutive neuronal NOS (nNOS or NOS I) and 
endothelial NOS (eNOS or NOS III) are highly regulated by calcium and calmodulin. 
The third inducible form of NOS (iNOS or NOS II) binds calmodulin tightly and is thus 
relatively calcium-independent. However, recent findings suggest that eNOS and nNOS 
expression can also be induced and that in some tissues iNOS appears to be present at 
all times. The NO/NOS system is involved in reproduction and development of 
organisms at many levels such as follicular development, ovulation, embryo 
development and implantation, and spermatogenesis (Van Voorhis et al. 1994; 
Shukovski and Tsasfriri 1994; Bonello et al. 1996). Nitric oxide plays a biphasic role in 
reproduction: a narrow range of NO concentrations, usually low, will stimulate or 
enhance these early events in reproduction, but either a lack of NO or too much NO has 
negative consequences (Barroso et al. 1998, Hanafy et al. 2001). The biosynthesis of 
NO is significantly increased in uterus and cervix as demonstrated by Ali et al. 1997, in 
the rat during pregnancy as a consequence of an increased expression of iNOS. Nitric 
oxide was supposed to be necessary and sufficient for egg activation and fertilization 
(Kuo et al. 2000). It has been demonstrated that nitric oxide inhibits oocytes meiotic 
maturation and embryo development in rodents or that excessive generation of nitric 
oxide can induce oxidative stress and apoptosis (Barroso et al. 1998, Jablonka-Shariff et 
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al. 2000; Nakamura et al. 2002, Yoon et al. 2002). The deleterious effects of NO on 
embryo development and implantation may be partly responsible for low in vitro 
fertilization (IVF) success rates. Various investigators have sought to identify and 
determine the cellular localization of NOS isoforms in mammalian tissues. Using 
immunohistochemistry, Gouge et al. (1998), Jablonka-Shariff and Olson (1998) and 
Nishikimi et al. (2001) identified eNOS and iNOS in the mouse oocytes and early 
embryos. The three NOS were reported by Trangusch et al. (2003) in mouse oocytes 
and embryos by real time PCR. However, thesse authors studies, failed to quantify 
NOS-specific mRNA in different embryonic developmental stages. One of the current 
difficulties of the field is the lack of molecular details concerning the mechanism of NO 
action, due in part to lack of technology for effective detection of NO and its molecular 
targets (Thaler and Epel 2003). While considerable progress has been made in 
elucidating nitric oxide regulatory mechanisms in rodents, much less is known about its 
synthesis and role in early embryo development in farm animals. Understanding the 
physiological roles of nitric oxide synthase in oocyte maturation, fertilization and 
embryo development is of great importance in reproduction improvement. Given the 
growing importance of NO as a messenger in the oocyte or embryo and the minimal 
information regarding its production and role in cattle, the present study was undertaken 
with the following objectives:  
I. Investigation of the physiological role of NOS/NO system on bovine embryo 
development, using dosage dependent application of N-omega L-nitro arginine methyl 
ester, (L-NAME) a selective inhibitor of NO production at maturation or/and culture 
medium. 
II. Identification of nitric oxide synthase gene isoforms in bovine oocytes and/or 
preimplantation embryos with help of polymerase chain reaction (PCR) 
III. Quantitative expression profiling of the NOS genes in bovine ooctes and 
preimplantation embryos using real-time PCR technology 
IV. Detection and localization of NOS protein in bovine oocytes and preimplantation 
embryos using immunohistological analysis  
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2 Literature review 
 
2.1 Cattle embryo production and development 
 
In vitro production (IVP) and multiple ovulation and embryo transfer (MOET) progress 
through scientific research to field testing and end up in commercial application. 
Immature oocytes recovered, matured, fertilized and cultured in vitro to blastocyst stage 
are either transferred to recipients immediately or frozen for transfer at a later date. 
Oocytes can originate from the ovaries of live intact animals or recovered from ovaries 
after slaughter.  
 
2.1.1 Developmental competence 
 
Developmental competence is the ability of the oocyte to produce normal, viable and 
fertile offspring after fertilization. The developmental competence of the oocyte is 
acquired within the ovary during the stages that precede ovulation or in case of in vitro 
maturation, precede the isolation of the oocyte from its follicle (Mayes 2002). It is a 
difficult parameter to assess since embryonic development may fail due to reasons 
independent of oocyte quality. Developmental competence is usually expressed as the 
percentage of oocytes that can develop to the blastocyst stage (Gandolfi 1997). 
However, development to the blastocyst stage does not guarantee that the embryo will 
develop to term. Other aspects used to evaluate developmental competence include 
morphological evaluations, such as number of blastomeres or the ratio between inner 
cell mass and trophoectoderm cell numbers and metabolic rates (Crosier et al. 2001). 
The size and the quality of the follicle of origin (Hazeleger et al. 1995) influence the 
developmental capacity of bovine oocytes. It appears that the oocyte requires an 
additional "prematuration" to express their competence (Hendriksen et al. 2000). If in 
vivo, this pre-maturation occurs during preovulatory growth before the lutenising 
hormone (LH) surge, the ovarian morphology, the number and size of the follicles 
present in the ovary at the time of aspiration, the composition of the follicular fluid 
(Hazeleger et al. 1995, Madison et al. 1992, Lonergan et al. 2003a) may be critical for 
the oocyte to acquire developmental competence. The developmental competence of the 
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oocyte may also be lost during in vitro maturation since the number and quality of 
cumulus cells surrounding the oocyte are important in this process (Blondin and Sirard 
1995, Gandolfi et al. 1997).  
The absence of reliable markers for the identification of viable embryos for transfer at 
the early cleavage stage is likely to contribute to the generally low implantation rates in 
IVF treatment (Fenwick et al. 2002). Early cleavage is indicative of increased 
developmental potential in embryos and may be useful as a criterion in the selection of 
embryos for transfer. To improve the selection of the embryo with the highest 
implantation potential, Van Montfoort et al. (2004) suggested that selection for transfer 
should not be based on cell number and morphology on the day of transfer alone, but 
also on early cleavage status. 
 
2.1.2 Oocyte maturation 
 
Oocyte maturation is a complex phenomenon during which the oocyte progresses from 
the diplotene to the metaphase II stage (nuclear maturation). The oocyte resumes 
meiosis in response to the ovulatory LH surge or removal from the follicle. In cattle, 
germinal vesicle breakdown (GVBD) occurs within hours after removal from the 
follicle or the ovulatory LH signal. The oocyte remains arrested at the metaphase II 
stage until fertilization takes place and the oocyte completes meiosis and forms the 
pronucleus. However the completion of nuclear maturation alone does not guarantee 
subsequent embryo development (Yang et al. 1998). Oocyte maturation also involves 
transformations at the cytoplasmic level that prepare the cell to support fertilization and 
early embryonic development (cytoplasmic maturation). 
Oocytes matured in vitro or in vivo have similar rates of nuclear maturation, fertilization 
and cleavage, but clearly differ in their developmental potential (Sirard and Blondin 
1996). Differences in development between in vivo and in vitro cultured bovine oocytes 
are expressed at the morula-blastocyst stage (Farin and Farin 1995). Important factors 
either in the form of proteins or stable mRNAs are stored during oocyte growth and 
final follicular maturation after the growth has been completed (Blondin and Sirard 
1995). The ability of the oocyte to complete meiosis is known as meiotic competence, 
which is acquired gradually during follicular growth. It is closely correlated with oocyte 
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size, which in turn is correlated with follicle size (Armstrong 2001) and the size of the 
antral follicle at which the oocyte acquires meiotic competence is species-specific 
(Mayes 2002). Cleavage and blastocyst rates increased in parallel with meiotic 
competence and significantly higher developmental rates have been obtained when the 
diameter of fertilized oocytes is greater than 120 µm (Hazeleger et al. 1995). Once the 
oocyte becomes meiotically competent, inhibitory factors are necessary to maintain the 
oocyte in meiotic arrest. The nature of meiotic arrestor in bovine (follicles) is poorly 
understood. Nitric oxide synthase derived nitric oxide system seemed to be implicated 
in this process (Nakamura et al. 2002). The regulation by the interplay of cyclic 
adenosine monophosphate (cAMP) of cell-cell interactions between granulosa and 
cumulus cells and the oocyte in mediating maintenance of meiotic arrest was 
hypothesized by Aktas et al. 2003. Cumulus expansion and oocyte developmental 
competence are induced by different cAMP (Luciano et al. 2004). 
 
2.1.3 Nitric oxide in embryo growth and development 
 
Growth and development rates are important indicators of embryo viability (Morris et 
al. 2000). Cattle embryo growth and development is characterized by cell proliferation 
and differentiation, gene expression and protein synthesis. The signal transduction 
systems, cAMP and cGMP are an integral part of these processes. Many hormones, 
neurotransmitters and other `first messengers' like nitric oxide act by regulating the 
synthesis or breakdown of cAMP or cGMP. It has been established that from day 13 to 
day 16 intracellular and extracellular concentrations of cAMP and cGMP decreased, 
consistently with the decrease in protein synthesis, phosphorylation and metabolic 
activity (Morris et al. 2001). The pathway by which NO will affect transduction 
depends on its concentration and the molecular environment (Hanafy et al. 2001). 
Specifically, high concentrations of NO can result in autooxidation or nitrosylation. 
Besides the concentration of NO, the existence of strong oxidants in the environment, 
such as superoxide radical can also modify NO, forming peroxynitrite, which reacts 
with the phenol moiety in tyrosine resulting in nitrotyrosine. A summary of the low and 
high concentration effects of NO is provided in figure 1. Guanylate cyclase catalyzes 
the formation of cGMP, which is utilized as an intracellular amplifier and second 
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messenger in modulating the function of protein kinases, phosphodiesterases, ion 
channels, smooth muscle tone regulation and the inhibition of platelet adhesion (Dröge 
2002). 
Effects of NO at
>1µM
Effects of NO at
<1µML-ARGININE
NITROSYLATION
Cys-NO NITRIC OXIDE
SYNTHASE
NO
L-CITRULLINE
TRANSFORMATION
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Figure 1: Summary of nitric oxide transduction (Hanafy et al. 2001) 
 
2.1.4 Genetic control of early embryonic development 
 
Mammalian embryogenesis is not totally explored, may be due to currently lack of 
appropriate technique and the difficulty in obtaining sufficient amounts of timed 
embryos. 
 
Maternal gene expression 
 
Oogenetic mRNAs and proteins are required to confer normal or full developmental 
competence. During early stage of development accumulated transcript, 
macromolecules and proteins are of importance as mentioned by De Sousa et al. 
(1998a) and Trounson et al. (2001). Variations in level of transcript abundance (relative 
mRNA) between groups (in vitro/in vivo, immature/matured, follicle size) of some 
genes related to developmental competence in bovine oocytes have been reported 
(Lonergan et al. 2003b). Transcription activity in bovine oocytes during folliculogenesis 
begins as early as the secondary follicle stage (Fair et al. 1997). Bovine germinal vesicle 
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stage demonstrated transcriptional activity significantly higher than mature oocyte 
(Memili et al. 1998). Among gene transcripts required for oocyte development 
identified by De Sousa et al. 1998a in mouse like c-mos proto-oncogene, connexin 37, 
growth differentiation factor-9 (GDF-9), zona pellucida glycoproteins (ZP1, ZP3 and 
ZP3), we can include NOS. 
 
Embryonic gene activation 
 
If gene expression of maternal origin is necessary, it is not sufficient to insure further 
development. Embryonic gene activation (EGA) where embryo begins to synthesize its 
own mRNA and protein (taking place of the inherited one from the mother in the egg) is 
required (Schultz 1993). The transition from the maternal to embryonic control of early 
embryonic development in mammals takes place at different periods, depending on the 
species (reviewed by Kanka 2003) and starts as early as the one- to 2-cell stage in mice, 
at the four- to eight- cell stage in humans. Although the bovine maternal-zygotic 
transition occurs at the 8- to 16-cell stage and is characterized by a major onset of 
transcription, minor transcription is observed as early as the one-cell embryo (Memili 
and First 1999). Many genes of potential role in early transcription during bovine 
embryo development are reported by Vignault et al. 2004.  
At which level of embryonic development are nitric oxide synthase genes involved still 
to be investigated. NOS mRNA aspect, their protein patterns after NO synthesis 
inhibition by L-NAME will allow us to determine their role before fertilization and at 
early bovine stage of development. NOS genes structure, regulation and NO role plus 
mechanism of action in other tissues are reviewed in the following section. 
 
2.2 Nitric oxide synthase genes 
 
Nitric oxide is ubiquitous in that it is found in virtually all tissues; however, NOS types 
appear to be tissue-specific (Boucher et al. 1999). 
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2.2.1 Nitric oxide synthase structure 
 
Three NOS isoforms, sharing a common basic structural organization and requirement 
for substrate cofactors to enable enzymatic activity, have been described in mammals as 
illustrated in figure 2. Two of these genes, neuronal nitric oxide synthase (nNOS or 
NOSI) and endothelial nitric oxide synthase (eNOS or NOSIII) were supposed 
constitutively expressed, calcium-calmodulin dependent and produced small amount of 
nitric oxide (NO) in response to transient elevation in intracellular calcium. It is 
becoming clear now that they are modulated by a lot of factors in tissue specific ways 
(Boucher et al. 1999). Inducible nitric oxide synthase (iNOS or NOSII) functions 
independently of a rise of intracellular calcium. The three isoforms of NOS, although 
products of distinct genes, share 50-60 % homology at the nucleotide and amino acid 
levels and are functional only as homodimers (head-to-head) (Murphy 2000). Each 
NOS isoform has similar catalytic domains (Mayer and Andrew 1998): a reductase (C-
terminal) exhibiting binding sites for flavins and NADPH, and an oxygenase (N-
terminal) domain that contains heme and the site for tetrahydrobiopterin (BH4) binding.  
Till date only bovine eNOS is totally characterized whereas iNOS is partially 
sequenced. The bovine eNOS gene spans 20 kb and contains 26 exons and 25 introns 
plus 2.9 kb of 5'-flanking sequence (Venema et al. 1994). Evolutionary conservation of 
transcriptional regulation is suggested by these authors since high sequence homology 
of the promoter region to the human eNOS gene promoter was found (75 % nucleotide 
identity in 1.6 kb of 5'-flanking sequence). 
 
 
 
 
 
 
 
 
 
Figure 2: Domain structure of human nNOS, eNOS and iNOS (Alderton et al. 2001) 
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2.2.2 Other isoform: mitochondrial NOS 
 
The existence of a nitric oxide synthase that is localized in the mitochondria (mtNOS) 
was described but this finding was supposed to be one of the recognized NOS isoforms 
targeted to the mitochondria after protein synthesis in the cytosol (Kanai et al. 2001). It 
was reported that the eNOS isoform was localized to the inner mitochondrial membrane 
in all tissues that were tested, including brain, kidney, liver, skeletal and cardiac muscle. 
More in-depth studies using a variety of NO detection techniques adding further support 
for the existence of an mtNOS were unable to determine whether the enzyme was novel 
or related to the nNOS, iNOS and eNOS isoforms. Only extended studies to the 
investigation of the functional implications of mtNOS and use of a NO-sensitive dye to 
stain the mitochondria in intact cells demonstrated the presence of NO within these 
organelles (López-Figueroa 2000). Despite a number of positive reports, scepticism 
remains regarding the existence of an mtNOS. In fact high altitude significantly 
increased heart mtNOS activity (Gonzales et al. 2005). But they observed using western 
blot analysis that heart mitochondria reacted only with anti-iNOS antibody, whereas the 
postmitochondrial fraction reacted with anti-iNOS and anti-eNOS antibodies. 
 
2.2.3 Regulation of nitric oxide synthase  
 
Nitric oxide is now known to be synthesized in a large number of different tissues and 
playing a wide range of physiological roles. Due to its potential cytotoxicity, the 
unregulated production of NO may be detrimental to tissues (Park et al. 1997). The 
regulation of NOS activity in order for NO to perform this variety of roles is complex. 
Cellular and tissue specific localization of the NOS isoforms by transcriptional 
(Alderton et al. 2001), translational and posttranscriptional (Kone et al. 2003) regulation 
have been reported.  
 
2.2.3.1 Regulation of nitric oxide synthase activity 
 
Elucidation of the mechanisms and factors determining transcription of the NOS genes 
under different physiological/pathophysiological conditions is crucial to understand the 
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alterations in vascular NO production (Fleming and Busse 2003). They investigated also 
the stimuli associated with the effects on NOS protein levels (oestrogen, TNF and shear 
stress) to regulate posttranscriptional processes that mainly determine NOS mRNA 
stability after studies on the activity of the NOS promoter and changes in NOS mRNA 
expression.  
 
Regulation of NOS mRNA 
 
Steady-state mRNA levels represent the balance between gene transcription and mRNA 
degradation. The half-lives of mRNAs (modulated in response to extra- and/or 
intracellular signals) in mammalian cells varies from minutes to many hours and the 
translation has a critical role in the regulation of mRNA stability (Bloch 1999). There is 
a marked discrepancy among amounts of eNOS mRNA, protein, and activity, 
demonstrating complex regulatory mechanisms after transcription and translation. 
Messenger RNA stability is regulated by protein/mRNA interactions (Searles et al. 
1999). Posttranscriptional mechanisms have emerged as important regulatory pathways 
in the decrease of eNOS expression with mRNA destabilization playing a significant 
role in the rapid downregulation of eNOS mRNA levels (Tai et al. 2004).  
 
Nitric oxide synthase dimer formation 
 
Nitric oxide synthase activity requires not only binding of calomodulin and 
tetrahydrobiopterin (BH4) but also the formation of a homodimer. Homodimers of NOS 
differ markedly in the association strength of their monomers, their full interfaces, and 
the influence of L-arginine and BH4 on their formation and stability (Kone et al. 2003). 
Homodimerization depends on the binding of L-arginine, stoichiometric amounts of 
heme, and BH4 (Stuehr 1996). In turn, dimerization potentiates NOS activity by 
creating high-affinity binding sites for L-arginine and BH4, removing heme from the 
solvent phase, and facilitating electron flow from the reductase domain to the oxygenase 
domain (Crane et al. 1999, Li et al. 1999). Studies have indicated that only the 
oxygenase domain is involved in iNOS dimer formation, whereas interactions between 
the reductase domains and between the reductase and oxygenase domains are critical for 
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dimerization of nNOS and eNOS (Venema et al. 1997). Using complementation 
analysis, Xie et al. (1996) found that binding of one molecule of BH4 was sufficient for 
dimer formation and iNOS activity. In contrast, the binding of one molecule of heme 
sustained dimerization but not enzymatic activity. The active site requires two hemes 
whereas; the BH4 could be supplied by the same chain that took in electrons from 
NADPH, or by the other chain.  
 
Degradation/proteolysis of nitric oxide synthase 
 
Selective proteolytic degradation of NOS is one of the mechanisms for regulation of 
NOS enzyme (Osawa et al. 2003). NOS degradation is influenced by diverse agents, 
including glucocorticoids, caveolin-1, heat shock protein (Hsp) 90, neurotoxic 
molecules and certain NOS inhibitors (Kone et al. 2003). The calpain and ubiquitin-
proteasome pathways, dexamethasone promotes proteolysis of iNOS in rat glomerular 
mesangial cells (Kunz et al. 1996) whereas neutral cysteine protease calpain I act on 
iNOS monomer as a direct substrate for degradation (Walker et al. 2001). L-arginine 
and tetrahydropterin by facilitating dimerization of the monomers protect iNOSox and 
nNOSox dimers against trypsin proteolysis, whereas the eNOSox dimer is resistant to 
proteolysis under all conditions (Panda et al. 2002).  Kolodziejski et al. (2003) showed 
that intracellular iNOS forms dimers that are "undisruptable" by boiling, denaturants, or 
reducing agents.  
 
Calcium-calmodulin 
 
Calmodulin interacts with NOS and is necessary for the enzymic activity of all three 
isoforms. The calcium-dependence of NO synthesis distinguishes the NOS isoforms, 
with nNOS and eNOS having a much higher calcium requirement than iNOS. 
Calmodulin binding increases the rate of electron transfer from NADPH to the 
reductase domain (Boucher et al. 1999) and also triggers electron transfer from the 
reductase domain to the heme centre. Neuronal NOS and eNOS differ in their primary 
structure from iNOS, having inserts in the middle of the FMN-binding subdomain, 
which has been described as an auto-inhibitory loop, and acts by destabilizing 
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calmodulin binding at low calcium and by inhibiting electron transfer from FMN to the 
heme in the absence of calcium -calmodulin (Alderton et al. 2001). 
 
Tetrahydrobiopterin (BH4) and phosphorylation 
 
Tetrahydrobiopterin plays a key role in dimmer formation from monomers, stability of 
dimeric NOSs, and NO formation (Griscavage et al. 1994). Crystallographic data show 
that dimerization results in strong modifications of the monomeric protein, including 
interactions between tetrahydrobiopterin and the heme carboxylate group, the a-NH2 
group of L-arginine, and residues involved in the dimer interface (Boucher et al. 1999).  
Phosphorylation of the nNOS and eNOS isoforms has an effect on their enzyme 
activity. Serine (Ser) at active site of eNOS is phosphorylated by protein kinase Akt 
which results in an increase in NO production (Michell et al. 2002). In contrast, the 
phosphorylation of nNOS at Ser by calmodulin-dependent kinases leads to a decrease in 
its activity (Alderton et al. 2001). In unstimulated, cultured endothelial cells, Ser1177 is 
not phosphorylated but is rapidly phosphorylated after the application of fluid shear 
stress, estrogen and VEGF, insulin or bradykinin in human endothelial cells (Fleming 
and Busse 2003). The negative regulatory site Thr495, is constitutively phosphorylated in 
all of the endothelial cells: its phosphorylation is associated with a decrease in enzyme 
activity (Fleming et al. 2001). Changes in Thr495 phosphorylation are generally 
associated with bradykinin and histamine that elevate endothelial intracellular calcium 
and increase eNOS activity. 
 
Other protein interaction 
 
Endothelial NOS-associated protein-1 (ENAP-1) is tyrosine phosphorylated in response 
to bradykinin stimulation of eNOS in bovine endothelial cells. Kalirin appears to inhibit 
iNOS by preventing the formation of iNOS dimers and may play a neuroprotective role 
during inflammation. Dynamin 2 is supposed to associate with endothelial NOS, in the 
Golgi apparatus (Cao et al. 2001) and an increase in dynamin levels results in enhanced 
eNOS catalysis by means of direct protein interactions (Dessy et al. 2000).  
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2.2.3.2 Regulation of nitric oxide synthase localization 
 
NO production is not simply dependant on the expression of the (endothelial) NOS 
enzyme but is determined by an (endothelial) NOS signaling complex that consists of an 
enzyme and a conglomerate of adaptor proteins, structural proteins, kinases, 
phosphatases, that affect complex association and determine intracellular localization 
(Fleming and Busse 2003). The main localization of NOS isoforms have been reported 
by Boucher et al. (1999) and summarized in table 2.1 below. 
 
Table 2.1: Main localizations of the three NOS isoforms in rat (Boucher et al. 1999) 
 
Isoform  nNOS  iNOS  eNOS  
 
 Type    constitutive inducible    constitutive (but regulated) 
 Subcellular   cytosol  cytosol    membrane and cytosol 
 localization 
 Cell, tissue   brain  liver     endothelium 
    neuron hepatocyte    epithelial cell 
    lung  chondrocyte  
    kidney macrophage 
     smooth muscle 
 
Myristoylation and palmitoylation  
 
Endothelial NOS is acylated by both myristate and palmitate and thus can associate with 
intracellular membranes. This membrane association is required for the phosphorylation 
and activation of eNOS in response to stimuli such as VEGF (Fulton et al. 2002). 
Functional eNOS was detected in three membrane compartments, the plasma membrane 
(Hecker et al. 1994), plasmalemmal caveolae (Liu et al. 1996) and the Golgi apparatus 
(Fulton et al. 2002). Busconi and Michel (1993) suggested that N-terminal 
myristoylation of the endothelial NOS may determine subcellular localization. 
Palmitoylation is dynamically regulated by agonist and is necessary for efficient 
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localization of eNOS to the plasmalemmal caveolae of endothelial cells. The main 
pathway leading to a functional eNOS enzyme is depicted in the figure 3 showing some 
transcriptional regulation, (de)stabilization of eNOS mRNA, and protein-protein 
interactions. Once the enzyme is functional, the presence of substrate arginine and 
cofactor BH4 determines whether eNOS is producing nitric oxide (NO) or superoxide 
(Govers and Rabelink 2001). 
           
eNOS gene
mRNA
eNOS protein
Myristoylation
Palmitoylation
mRNA
degradation
Transcription
Translation
Protein-protein interaction
Phosphorylation
SuperoxideNO
BH4
Arginine
Shaer stress
Oestrogen
EPO
Hypoxia
Calmodulin
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+
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Figure 3:  Cellular events involved in the regulation of endothelial NOS activity  
 (Govers and Rabelink 2001) 
 
Regulation of inducible nitric oxide synthase 
 
Numerous cytokines and microbial products, acting in synergy, stimulate expression of 
iNOS but the effective agents and combinations depend on cell type and species. It is 
difficult to tell whether iNOS in epithelium is expressed "constitutively" or is 
continually "induced" (MacMicking et al. 1997). Indeed certain cells in the normal rat 
kidney and ovarian follicles during certain phases of the cycle express iNOS (Van 
Voorhis et al. 1995). Calcium ionophores enhance induction of iNOS mRNA by LPS in 
macrophages but increased intracellular calcium suppresses interleukin-1 (IL-1)-
induced nitric oxide production in human chondrocytes by reducing the stability of 
iNOS mRNA (Geng and Lotz 1995). In mouse it has been demonstrated that iNOS 
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induction by IFNγ and LPS was transcriptional (Xie 1997), although there may be an 
additional effect on mRNA stability. Multiple transcriptional initiation sites have been 
observed in human iNOS at the 5’ UTR (Chu et al. 1995). Interleukin 4 exerts a delayed 
suppressive effect on transcription of iNOS (Bogdan et al. 1994) whereas interleukin 
10's suppressive effect is exerted indirectly via its suppression of TNF production.  At 
posttranscriptional regulation, the most potent suppressors of iNOS expression in mouse 
macrophages are TGFβ1-3 (Vodovotz et al. 1994) which destabilized iNOS mRNA, 
retarded the synthesis of iNOS protein, and accelerated its degradation. Posttranslational 
regulation through availability of heme or BH4 has been reported (Albakri and Stuehr 
1996). Heme depletion is implicated for the loss of iNOS enzyme activity in 
macrophages (Vodovotz et al. 1994, Nathan and Xie 1994). 
 
Regulation of neuronal nitric oxide synthase 
 
The majority of nNOS immunoreactivity in neurons is associated with endoplasmic 
reticulum and within specialized electron-dense synaptic membrane structures and 
postsynaptic densities. Although nNOS was first characterized as a soluble (cytosolic) 
protein, this protein undergoes an important association with the sarcolemma in skeletal 
muscle (Michel and Feron 1997). Neuronal NOS is expressed as catalytically active N-
terminally truncated forms that are required for dimer assembly and catalysis (Panda et 
al. 2003). Sagami et al. (2001) confirmed that the mechanism of activation of nNOS by 
calmodulin is not solely dependent on the activation of electron transfer to the hemes 
but may align adjacent reductase and the oxygenase domains as proposed by Panda et 
al. (2001). Tetrahydrobiopterin is a critical element in the nNOS metabolism of L-
arginine to L-citrulline and NO or superoxide (Rosen et al. 2002). 
 
2.2.3.3 Nitric oxide synthase inhibition  
 
If NOS enzymes are regulated in part by post-translational proteolysis, then certain 
types of NOS inhibitors can enhance the degradation of NOS protein as reported by Wei 
et al. (1998) and Vuletich et al. (2002). Most NOS inhibitors vary in their affinities for 
the isoforms of NOS (Rosselli et al. 1998), and analogs of L-arginine act as competitive 
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inhibitors reversible by addition of excess L-arginine, although prolonged exposure may 
cause irreversible inhibition. The most commonly used inhibitors have been 
aminoguanidine, N-mono-methyl L-arginine (L-NMMA), N-nitro-L-arginine (L-NNA) 
and its methyl ester: NG-nitro-L-arginine methyl ester (L-NAME)(Rees et al. 1990 and 
Reif et al. 1995). Some NOS inhibitors, NO donors and scavengers with their activity 
sites are illustrated in figure 4 below. 
   
Figure 4:  Schematic presentation of the NO/cGMP pathway, its inhibitors and 
activators (Revelli et al. 2002) 
 
Inhibitors of nitric oxide synthase: arginine analogs  
 
Competitive inhibitors bind with about tenfold higher affinity than L-arginine to the 
substrate site of NOS. N-nitro-L-arginine (L-NNA) is the active NOS inhibitor formed 
by hydrolysis from the inactive prodrug N-nitro-L-arginine methyl ester (L-NAME) and 
exhibits a fairly pronounced selectivity towards the constitutive isoforms (Mayer and 
Andrew 1998). Although the binding affinity of L-NNA is similar to that of N-methyl-
L-arginine (L-NMA), it triggers a rapid, turnover-independent enzyme inactivation that 
is accompanied by a complete blockade of NADPH-dependent heme reduction. 
Dissociation of the L-NNA-NOS complex is slow, rendering L-NNA a highly potent 
tight-binding inhibitor of the constitutive isoforms (Mayer and Andrew 1998). Potent 
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and selective inhibitors of iNOS were shown to prevent iNOS dimerization in cells 
(McMillan et al. 2000). The inhibitors bind to a heme-containing iNOS monomer 
species to form an inactive iNOS monomer-heme-inhibitor complex in a BH4- and L-
arginine-independent manner by allosterically disrupting protein-protein interactions at 
the dimer interface. The energetics and kinetics of monomer-dimer equilibria are 
substantially different for the mammalian NOS isoforms (Blasko et al. 2002). 
Affinity/selectivity or potency/selectivity of NOS inhibitors, particularly substrate 
analogs in human are given in Table 2.2a and 2.2b. Selective substrate analogs with 10- 
to 30-fold selectivity for the constitutive isoforms (neuronal and endothelial NOS) are 
L-NA and L-NAME but L-NAME is 30- to 100-fold less potent than L-NA (Boer et al. 
2000). In contrast Abu-Soud et al. (1994) showed that L-NAME inhibits NOS NADPH 
uptake through binding within the substrate binding site in iNOS and nNOS. L-NAME 
abolished the increased nitrite production due to up-regulation of iNOS-eNOS mRNA 
and protein in activated mouse macrophages or bovine pulmonary artery endothelial 
cells (Zuo and Johns 1997). 
 
Table 2.2a:  Affinity and selectivity of NOS inhibitors of human isoenzymes  
(Boer et al. 2000) 
 Compound    Affinity   Selectivity 
iNOS  nNOS  eNOS       i-/eNOS i-/nNOS n-/eNOS 
 Substrate analogs        pIC50 value ± SD    ratio 
 L-NA  5.5 ± 0.1  7.33 ± 0.02  7.04 ± 0.05  0.03  0.02    2 
 L-NAME 4.5 ± 0.1  6.12 ± 0.02  5.82 ± 0.02  0.05   0.02    2 
 L-PA    4.0 ± 0.1  5.40 ± 0.1  5.06 ± 0.03  0.1   0.04    2 
 L-NMMA 5.58 ± 0.04 6.60 ± 0.1   6.50 ± 0.10   0.1  0.1    1 
 L-NIO 5.8 ± 0.1  6.02 ± 0.03  6.00 ± 0.01  1   1    1 
 L-VNIO  6.1 ± 0.1 6.40 ± 0.1  5.85 ± 0.04   2  0.5   4 
 L-NIL  5.7 ± 0.2  5.4 ± 0.2  5.11 ± 0.04  4   2   2  
 S-me-TC  6.7 ± 0.1  7.4 ± 0.1  6.94 ± 0.03   1 0.2   3 
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Table 2.2b:  Potency and selectivity of NOS inhibitors at human isoenzymes 
 (Boer et al. 2000) 
 Compound   Potency (logIC50-value)   Selectivity 
iNOS   nNOS    eNOS       i-/eNOS   i-/nNOS   n-/eNOS 
 Substrate analogs        pIC50 value ± SD    ratio 
 L-NA  5.8 ± 0.1   7.5 ± 0.2  7.1 ± 0.2  0.05   0.02    3 
 L-NAME 4.3 ± 0.1   5.7 ± 0.2  5.6 ± 0.1  0.05   0.05    1 
 L-PA    4.6 ± 0.2   6.3 ± 0.2  5.7 ± 0.1  0.08   0.02    4 
 L-NMMA   5.9 ± 0.2   6.0 ± 0.2   6.5 ± 0.2   0.3  0.8            0.3 
 LCM;ONIO  6.6 ± 0.1   6.3 ± 0.2  6.2 ± 0.2  3   2    1 
 L-VNIO  6.15 ± 0.02 6.3 ± 0.1  5.84 ± 0.06   2  0.7   3 
 L-NIL  6.2 ± 0.1  5.3 ± 0.2  5.06 ± 0.05  14   8   2 
 S-me-TC  7.2 ± 0.1   8.1 ± 0.6   7.27 ± 0.04   0.9 0.1   7 
 
Possible feedback inhibition of nitric oxide synthase by nitric oxide 
 
Enzymes that form a reduced-ferrous-heme intermediate have the potential to be 
inhibited by nitric oxide due to the stability of ferrous nitrosyl complexes (Alderton et 
al. 2001). Both iNOS and nNOS can form inhibitory nitrosyl species during turnover 
(Abu-Soud et al. 1995). Perez-Sala et al. (2001) found that inhibition of iNOS activity 
could be reversed by NO donors but with the time a subsequent inhibitory effect of NO 
donors on iNOS protein and mRNA levels is reached suggesting that NO may 
contribute to iNOS induction and downregulation. NO can modulate its own production 
by interfering with NFk-B interaction with the promoter region of the iNOS gene (Park 
et al. 1997). Nitric oxide interacts with enzyme-bound ferric heme to inhibit neuronal 
NOS activity and this inhibition was reversed by BH4 (Griscavage et al. 1994). In 1995 
Ravichandran et al. who showed reversible inhibition of semi purified eNOS enzymatic 
activity by NO and its donors confirmed that interaction of NO with the heme prosthetic 
component of NOS may lead to inhibition of their activity. Nitric oxide as a negative-
feedback regulator of endothelial isoform expression (via cGMP) was proposed by 
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Vaziri and Wang (1999). A negative feedback effect may be necessary for limiting 
nitric oxide production. 
 
2.3 Nitric oxide synthase expression in female reproductive tract and gonad tissue 
 
Nitric oxide synthase genes are expressed in a variety of mammalian reproductive 
tissues including ovary, uterus, vagina, oocyte in mouse suggesting regulatory roles of 
the NO in oocyte meiotic maturation, fertilization and even embryo development and 
implantation (Novaro et al. 1997, Gouge et al. 1998, Biswas et al. 1998, Purcell et al. 
1999, Jablonka-Shariff and Olson 2000, Sengoku et al. 2001, Tranguch et al. 2003). 
 
2.3.1 Uterus and vagina 
 
The presence of NOS has been shown by various studies in mammals. In rat uterus 
tissue (nonpregnant and at gestation), eNOS and iNOS have been reported whereas 
nNOS was not detectable (Farina et al. 2001). In early embryonic loss, the cytotoxic 
mechanisms involving natural killer cells and mononuclear cells in resorbing compared 
to non-resorbing embryos showed the involvement of nitric oxide in mice (Haddad et al. 
1995). In rabbit, Al-Hijji et al. (2000) reported that NOS activity was downregulated by 
estrogen and progesterone in uterus while the relatively high NOS activity was down 
regulated by estrogen and up regulated by progesterone in vagina. At uterine level, 
throughout gestation myometrial NO-production is upregulated and contributes to 
achieve uterine quiescence. Close to term, its production decreases promoting effective 
contractions resulting in labor (Ali et al. 1997). For cervical ripening, in contrast to the 
myometrium, NO-production in the cervix is low during pregnancy and becomes 
upregulated once pregnancy advances to term in mouse (Maul et al. 2003); in human at 
delivering (Väisänen-Tommiska et al. 2004) and postpartum (Tschugguel et al. 1999). 
 
2.3.2. Ovary 
 
Nitric oxide synthase have been implicated in several aspects of ovarian functions. 
Nitric oxide has emerged as one of several important intraovarian regulatory factors in 
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particular, in the processes of ovulation and atresia-related apoptosis. In the ovary nitric 
oxide is expressed not only by neurons and vasculature but also by other cell types like 
granulosa and theca at the follicle level, and luteal cells after ovulation (Zackrisson et 
al. 1996, Basini et al. 1998, Tamanini et al. 2003). Both eNOS and iNOS are expressed 
depending on animal species and different ovarian processes. In fact, eNOS presence 
has been reported in thecal, granulosa, luteal cells in human, rat, and pig by Van 
Voorhis et al. (1994), Jablonka-Shariff et al. (1997) and Takesue et al. (2001) 
respectively. On the other hand, iNOS has not been found in granulosa cells in rat 
(Jablonka-Shariff et al. 1997) whereas this isoform has been indicated by Van Voohris 
et al. (1995) and Zackrisson et al. (1996) respectively in rat granulosa cells from 
preovulatory follicles; stroma, thecal and luteal cells. In 2000 Matsumi et al. have 
demonstrated that inducible nitric oxide synthase is predominantly localized in 
granulosa cells of healthy immature follicles in the rat ovary whereas, granulosa cells of 
either healthy mature follicles or atretic follicles are devoid of iNOS. In bovine 
granulosa cells NO production by endothelial and inducible NOS, which are regulated 
by gonadotropins has been proposed by Schoenfelder et al. (2003) after Basini et al. 
(2000) who did not define which isoform was implicated in nitric oxide synthesis. 
Skarzynski et al. (2003) suggested that NO is not only produced in the bovine corpus 
luteum but it inhibits luteal steroidogenesis and it may be one of the components of an 
autocrine/paracrine luteolytic cascade induced by prostaglandin (PGF2α). Regulation of 
nitric oxide synthase isoforms and role of nitric oxide during PGF2α-induced luteolysis 
in rabbits is reported by Boiti et al. 2003 in rabbit.  
Locally produced nitric oxide is important for the maintenance and increase of rat 
ovarian blood flow during the preovulatory period (Mitsube et al. 2002). Nitric oxide 
influences apoptotic cell death of follicular cells as a follicle survival factor through 
hsp70 (Yoon et al. 2002, Takesue et al. 2003) and may inhibit oocyte meiotic 
maturation at ovulation, Nakamura et al. (2002) as illustrated in figure 5 where cumulus 
cell seem to play an important role (Tanghe et al. 2002). Nitric oxide seemed to be 
essential for optimal meiotic maturation of murine (Jablonka-Shariff and Olson 2000) 
and necessary for follicle rupture in rat (Shukovski and Tsafriri 1994, Hess et al. 2003). 
Endothelin-1 (ET-1) and NO (from iNOS) may modulate the production of each other in 
luteal microenvironment (Klipper et al. 2004). Nitric oxide was found to be involved in 
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the formation of hCG-induced murine follicular cysts since complications associated 
with these cysts were ameliorated by the NOS inhibitor L-NAME (Nemade et al. 2002). 
Many studies on NO have depended on the use of pharmacological inhibitors of NOS. 
However, the three NOS isoforms share L-arginine as a substrate and have similar 
enzymatic mechanisms. 
 
Figure 5: A scheme showing the different roles of the iNOS-NO and eNOS-NO 
systems in preovulatory follicles before and after hCG injection 
(Nakamura et al. 2002)  
 
Many NOS inhibitors cannot distinguish between the NOS isoforms, and there are no 
known inhibitors that are absolutely selective. Genetic approach circumventing the lack 
of specificity of NOS inhibitors is necessary to complement pharmacological 
approaches by making targeted deletions in the NOS genes as shown in the table 2.3 
below. 
 
2.4 NO/NOS expression in embryos 
 
Embryos have the necessary genes and proteins needed for protection against death and 
the development of strategies to reduce apoptosis in these embryos would be beneficial. 
It is therefore important to determine and if possible, prevent extrinsic factors that 
reduce embryo viability. The development of bovine embryos is supported by inorganic 
substrates, amino acids, carbohydrates, growth factors and antioxidants (Van Winkel 
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2001, Lim and Hansel 1998). Essential amino acids may support preimplantation 
blastocyst growth not only as nutrients but also as signaling molecules that influence 
protein kinases involved in protein synthesis regulation. Arginine is among the most 
effective essential amino acid signaling molecules, used as a substrate for the synthesis 
of polyamines and nitric oxide (Van Winkle 2001). 
 
Table 2.3:  Ovarian responsiveness in NOS deficient mice  
(Adapted from Gregg 2003) 
Authors  Mouse strain 
background 
Knock-out 
isoform  
Oocyte 
retrieved 
Litter 
size 
Methods 
Jablonka-shariff 
and Olson 
(1998) 
Mixed 
129Sv/C57BL6 
WT: 129Sv 
eNOS Reduced Reduced  
 
 
Super 
ovulation
 
Jablonka-shariff 
et al. (1999b) 
Mixed  
C57BL6/129Sv/Ev 
Mixed 
C57BL6/129Sv/Ev 
WT:129Sv/Ev 
eNOS 
 
iNOS 
Reduced 
 
Same 
 
 
Natural 
ovulation
Tempfer et al. 
(2000) 
C57BL6/J eNOS Reduced  Super 
ovulation 
Hefler and 
Gregg (2002) 
C57BL/6J 
129Sv 
C57BL/6J  
129Sv 
eNOS 
eNOS 
iNOS 
iNOS 
Reduced 
Same 
Same 
Same 
 Super 
ovulation 
Tranguch and 
Huet-Hudson 
(2003) 
C57BL6/J 
C57BL6/J  
B6129SF2/J101045 
Double knockout 
eNOS 
iNOS 
nNOS 
e/iNOS 
  Same 
Same 
Same  
Same 
Natural 
ovulation
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Immunocytochemistry method (Gouge et al. 1998, Nishikimi et al. 2001) for NOS 
localization, incubation with NO donors and/or NOS inhibitors (Barroso et al. 1998, 
Jablonka-Shariff et al. 1999a) was used in mouse or rate. NOS genes disruption 
(Jablonka-Shariff et al. 1999b, Hefler and Gregg 2002) for NO physiological role and 
now polymerase chain reaction (Tranguch et al. 2003) for NOS isoforms identification, 
have been used to study NOS expression in embryos in rodents. It is clear now that in 
mouse oocytes and preimplantation embryos all three NOS genes are expressed 
(Tranguch et al. 2003). According to Nishikimi et al. (2001) eNOS protein is localized 
in nucleus and cytoplasm, whereas iNOS is only found in cytoplasm. How NOS/NO 
production is modulated is still to be investigated. Whether nitric oxide is involved in 
early embryo normal development or/and death; embryotoxic stimuli: IFNγ, TNFα, LPS 
in mice and their ability to induce NO production by 2-cell stage embryos were 
examined by Athanassakis et al. (2000). Their results confirm the possible embryotoxic 
character of NO (more than 2 µM/embryo treated against undetectable in the control), 
leading to the hypothesis that NO plays a potential role in early embryo death in mice. 
The NO may control programmed cell death by up-regulation of the tumor suppressor 
p53, or by changes in the expression of Bcl-2 family members, cytochrome c relocation, 
activation of caspases, chromatin condensation, and DNA damage as shown in figure 6 
(Chen et al. 2001). According to these authors embryos cultured in vitro may be 
exposed to oxidative stress for which defence mechanisms are insufficient to protect 
delicate cellular structures from oxidative damage.   
Manser et al. (2004) demonstrated that mouse preimplantation embryos produce NO. 
Consumption of oxygen was correlated to the medium with or without addition of L-
NAME confirming that L-NAME is a specific inhibitor of NO production in embryo 
even if it is a non-selective NOS inhibitor. They hypothesized that NO may limit 
oxygen consumption at the blastocyst stage and by doing so participate to embryo 
developmental competence. Nitric oxide production at oocyte maturation, ovulation, 
fertilization, cleavage and implantation is reviewd by Thaler and Epel (2003). 
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Figure 6:  Hypothetical model for the role of NO in embryo implantation in which 
NO/cGMP pathway may increase blood supply and muscle relaxation in 
the endometrium and also be involved in the embryo development (A). 
In the patients with endometriosis, the inflammatory cells may produce 
excess NO to induce embryo apoptosis through the p53/Bax partway (B) 
(Chen et al. 2001) 
 
2.5 The role of nitric oxide 
 
Nitric oxide is a free radical gas, which plays a role in mammalian signaling and 
immunology (table 2.4). It plays a role in the brain as a neurotransmitter and in the 
control of blood flow (Huang and Fishman 1996). Nitric oxide causes vasodilation of 
blood vessels and by binding the heme of guanylate cyclase it exerts its effects at low 
concentration. It can be broken down by reaction with oxygen and/or haemoglobin. As a 
cytotoxin, in response to infection, macrophages synthesize NO, which is capable of 
cytotoxic and cytostatic effects on the invading organisms (Murphy 2000). Nitric oxide 
reacts with key metabolic enzymes, thus preventing continued metabolism, and is 
capable of combining with superoxide, generated in macrophages, to form peroxynitrite 
a potent agent of oxidative damage (Alderton et al. 2001). Since nitric oxide is 
diffusible, it may be able to exert its toxic effects outside the cell itself. Nitric oxide 
differs from other neurotransmitters and hormones in that it is not regulated by storage, 
release or targeted degradation, but solely by synthesis. Circulating nitric oxide products 
are increased during follicle development then decreased right after ovulation and 
iNOS-inhibition results in a 50 % reduction of ovulation (Maul et al. 2003). Nitric oxide 
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plays an important role before (sea urchin eggs activation: Kuo et al. 2000) and during 
embryonic development such as cell proliferation and differentiation in Drosophila, 
(Kuzin et al. 1996); at early development in mammals as reported by Jablonka-Shariff 
and Olson (1997), Gagioti et al. (2000), Nishikimi et al. (2001), Nakamura et al. (2002), 
Tranguch et al. (2003), Tranguch and Huet-Hudson (2003) by affecting embryos 
viability. For Sengoku et al. (2001), murine oocyte maturation, embryo development, 
and trophoblast outgrowth require nitric oxide in vitro. 
 
Table 2.4:  Possible role of nitric oxide (Huang and Fishman 1996) 
Biological tissue Function 
Central nervous system 
 
 
 
 
Peripheral nervous system 
 
Vasculature 
 
 
 
Heart 
Immune system 
Neural signaling molecule 
Retrograde messenger in long-term potentiation 
Mediator of excitatory amino acid neurotransmission 
Mediator of excitotoxicity 
Coupler of cerebrovascular blood flow to metabolism 
Neurotransmitter, smooth muscle relaxation 
Vasodilator, regulator of vascular tone  
Inhibitor of smooth muscle proliferation 
Inhibitor of platelet aggregation 
Inhibitor of leukocyte adhesion and activation 
Paracrine modulator of contractility and heart rate 
Defense mechanism against pathogens, tumor cells 
Mediator of homodynamic changes in sepsis 
 
 
It is still unclear by which mechanism NO plays its role at the embryonic level. It has 
been hypothesized that embryos with a lower amino acid turnover (a low metabolism 
probably mediated by NO), are developmentally more competent in human (Houghton 
et al. 2002). Other authors suggested that NOS activity during nidation is modulated by 
oestradiol and that NO production is necessary for successful embryo implantation 
(Novaro et al. 1996, Biswas et al. 1998, Ota et al. 2000). But Zhang et al. (2002) 
observed that reduction in the number of implanted embryos in L-NAME treated group 
 
Literature review   26
was associated with decreased matrix metalloproteinase 9 (MMP-9) activity and 
concluded that NO facilitates embryo implantation in mouse. 
 
2.5.1 Nitric oxide and infertility 
 
Early embryo loss is supposed to be associated to local production of NO from iNOS by 
decidual cells in mouse (Haddad et al. 1995). Recently it has been confirmed by 
Ogando and colleagues (2003) at the increased production of NO in LPS-induced 
embryonic resorption. Previously, iNOS expression by peritoneal macrophages in 
endometriosis was found to be associated with infertility in human (Osborn et al. 2002).  
Not only inducible isoform (Burnett et al. 2002) is implicated since, deletion of exon 6 
of the neuronal NOS gene in mice results in hypogonadism and infertility (Gyurko et al. 
2002). NOS deficient mice give more insight in the role of NO in ovulation (table 2.3). 
 
2.5.2 Nitric oxide and hypothalamic-pituitary-gonadal axis 
 
Nitric oxide plays a crucial role at every level of reproduction in the organism. It 
activates the release of luteinizing hormone-releasing hormone (LHRH) at 
hypothalamic level, which activates the release of gonadotropins by activating nNOS in 
the pituitary gland. Follicle stimulating hormone-releasing hormone (FSHRH) 
selectively releases follicle stimulating hormone (FSH) also by activating NOS 
(Rosselli et al. 1994). In the gonad, NO induces ovulation and causes luteolysis (Yang 
et al. 2003), whereas in the reproductive tract, it relaxes uterine muscles via cGMP and 
constricts it by prostaglandins (McCann et al. 2003). 
 
2.5.3 Nitric oxide in oocyte maturation, fertilization and embryo development 
 
During the brief period (12-24 h) of oocyte maturation in mammalian species, 
significant qualitative changes in protein synthesis occur to initiate and regulate 
resumption of meiosis (Fissore et al. 2002). Activation of maturation-promoting factor 
(MPF) [responsible for inducing germinal vesicle break down] and mitogen-activated 
protein kinase (MAPK) [plays a role in regulating the transition from meiosis I to 
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meiosis II or oocyte arrest at metaphase II] are of importance in cytoplasmic maturation. 
Bradykinin regulates interactions of the mitogen-activated protein kinase pathway with 
the endothelial nitric-oxide synthase (Bernier et al. 2000). The ability for cell to release 
calcium determines their viability or arrest in this process. The inositol 1, 4, 5-
triphosphate receptor (IP3R) is the channel of choice in calcium oscillations at 
maturation and fertilization (Fissore et al. 2002). Cyclic adenosine diphosphate ribose 
(cADPR) is a potent endogenous calcium-mobilizing agent (Willmott et al. 1996). In 
sea urchin eggs, nitric oxide activates a soluble guanylate cyclase resulting in the 
conversion of GTP to cGMP. The resulting cGMP elevation activates a cGMP-
dependent protein kinase leading to an increase in cADPR levels, which by binding to 
its receptor contributes to the opening of Ryanodine Receptor (RyR)-like calcium 
channel in the endoplasmic reticulum, resulting in a rise in calcium (figure 7). This 
hypothesis seemed to be possible in mammals since in human, calcium-binding proteins 
and calcium release channels in maturing oocytes, zygotes and early preimplantation 
embryos have been identified by Balakier et al. (2002). Comparative biology of calcium 
signaling during fertilization and egg activation in animals has been review in detail by 
Stricker 1999. Kuo et al. (2000) suggested after microinjection of NO donors or 
recombinant NOS that NO was not only necessary but sufficient for successful 
fertilization in sea urchin. Simultaneous measurement of intracellular nitric oxide and 
free calcium levels in mouse eggs demonstrate that nitric oxide plays no role in 
fertilization (Hyslop et al. 2001). Nakamura et al. (2002) hypothesized that NOS-NO 
system plays different roles in the outside and inside basement membrane of follicles 
before ovulation. According to these authors through cGMP, NO (especially from 
iNOS) inhibits oocytes maturation before ovulation and therafter by inhibition of 
MAPK. In 2003, Luckie et al. demonstrated that NO is unlikely to be the primary egg 
activator but, rather acts after the initiation of calcium wave to regulate the duration of 
fertilization in sea urchin. But phospholipase C zeta (PLCζ) that triggers calcium 
oscillations similar to those caused by sperm seemed to maintain the cell cycle-
dependent regulation of calcium oscillations following fertilization (Larman et al. 2004). 
It remains to be determined if an increase in PLC activity modulated by tyrosine kinases 
or other regulators necessarily requires receptor stimulation or if it may also occur in 
response to soluble sperm factors (Stricker 1999). Moreover, receptor-mediated and 
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sperm-factor-based pathways could function in concert during fertilization. Higher 
concentrations of nitric oxide (0.1 or 1 mM) inhibit embryo development (no 
development beyong 2-cell stage) in vitro and at implantation (no implantation sites) in 
vivo in mice as demonstrated by Barroso et al. (1998). 
 
 
Figure 7: Diagram of some possible components of fertilization-induced calcium 
signaling, showing receptor-mediated and sperm-factor based pathways 
as well as contributions from internal calcium release and external 
calcium influx (Stricker 1999).  
 
Recently, Manser et al. (2004) hypothesized that blastocysts with a higher 
developmental potential have reduced oxygen consumption, a characteristic that may be 
mediated by NO. The physiological role for NO in mouse preimplantation metabolism 
and development may be to limit oxygen consumption at the blastocyst stage at the level 
of mitochondrial cytochrome c oxidase. The existence of any hypothetical 
mitochondrial NOS could be easily explained by this assessment.  
 
2.5.4 Nitric oxide and apoptosis in embryos 
 
Preimplantation embryo depends on maternal mRNAs and proteins deposited and stored 
in the oocyte prior to its ovulation. If the oocyte is not sufficiently equipped with 
maternally stored products, or if zygotic gene activation does not commence at the 
correct time, the embryo will die (Jurisicova et al. 1998). Apoptosis is an evolutionarily 
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conserved mechanism for eliminating cells containing genetic damage from the 
developing organism. Therefore, activation of apoptosis in preimplantation embryos 
could act to restrict transmission of genetic damage; but, failure to activate apoptosis 
could result in the accumulation of damage in the foetus (Metcalfe et al. 2004). It is 
apparent that excess NO leads to degeneration of embryos while insufficient amounts of 
NO arrests development (Tranguch et al. 2003).  
In many tissues, NO mediates its effects through the cGMP pathway (Chen et al. 2001) 
as shown in preimplantation embryo development however, NO worked not exclusively 
through the cGMP pathway. It can promote apoptosis in some cells, whereas it inhibits 
apoptosis in other cells a consequence of the rate of nitric oxide production and the 
interaction with biological molecules such as iron, thiols, proteins, and reactive oxygen 
species (Chung et al. 2001). These authors demonstrated that long-lasting production of 
nitric oxide acts as a pro-apoptotic modulator by activating caspase family proteases 
through the release of mitochondrial cytochrome c into the cytosol, upregulation of p53, 
and altering the expression of apoptosis-associated proteins including Bcl-2 family.  
The ratio of Bcl-2 to Bax may be used to gauge the tendency of oocytes and embryos 
towards either survival or death (Yang and Rajamahendran 2002). They demonstrated 
that the expression of Bcl-2 was high in bovine good quality oocytes and embryos, low 
in fragmented embryos, and hardly detectable in denuded oocytes in contrast to Bax 
found in all types of oocytes and embryos with the highest expression in the denuded 
oocytes. However, low or physiological concentrations of NO prevent cells from 
apoptosis induced by trophic factor withdrawal, Fas, TNFα and LPS showing the 
double-edged role of nitric oxide suggested in preimplantation embryo apoptosis 
(Esfandiari et al. 2002). 
 
Materials and methods   30
3 Materials and methods:  
 
3.1 Materials 
 
In the present study bovine in vitro produced (IVP) embryos were used. Oocytes 
aspirated from ovaries obtained from nearby slaughter house were used in the IVP 
embryos.  
 
3.1.1 Media used for IVP 
 
Modified Parker Medium   
(MPM-110 ml) Sodium hydrogen carbonate            0.080 g 
 Hepes               0.140 g 
 Sodium pyruvate             0.025 g 
 L-Glutamin              0.010 g 
 Streptomycin phosphate            0.003 g 
 Penicillin              0.002 g 
 Medium 199              99.0 ml 
 Hemicalcium lactate             0.060 g 
 Water added to              110.0 ml  
  
Capacitation medium (50 ml) Sodium chloride              0.2900 g 
 Potassium chloride              0.0115 g 
 Sodium hydrogen carbonate             0.1050 g 
 Sodium dihydrogen phosphate          0.0017 g 
 Hepes                0.1190 g 
 Magnesium chloride & H2O             0.0155 g 
 Calcium chloride              0.0145 g 
 Sodium lactate solution (60 %)         184 µl 
 Phenol red solution (5 % in D-PBS) 100 µl 
 Water added to   50 ml  
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Fertilization medium (FM-50 ml)  
 Sodium chloride   0.3300 g 
 Potassium chloride   0.0117 g 
 Sodium hydrogen carbonate  0.1050 g 
 Sodium dihydrogen phosphate 0.0021 g 
 Penicillin G     0.0032 g 
 Magnesium chloride & H2O  0.0050 g 
 Calcium chloride   0.0150 g 
 Sodium lactate solution  93 µl  
 Phenol red solution (5 % in D-PBS) 100 µl  
 Water added to   50 ml  
  
Culture medium (CR1-50 ml) Hemicalcium lactate   0.0273 g 
 Potassium chloride   0.0112 g 
 Podium chloride   0.3156 g 
 Sodium pyruvate   0.0021 g 
 Penicillin G     0.0032 g 
 Magnesium chloride & H2O  0.0050 g 
 Calcium chloride   0.0150 g 
 L-Glutamin    0.0073 g 
 Phenol red solution (5 % in D-PBS)  100 µl 
 Water added to   50 ml  
 
Bovine embryo production in vitro 
 
Maturation medium: Modified Parker Medium (MPM): 
The above chemicals were dissolved in 100 ml TCM-199 in order to reach 728 µg/ml 
sodium hydrogen carbonate, 1.28 mg/ml hepes, 227 µg/ml sodium pyruvate, 91 µg L-
Glutamin, 55 µg/ml gentamycin and 545 µg/ml hemicalcium lactate already dissolved in 
10 ml water. The solutions are mixed thoroughly, sterile filtered and stored at 4 °C. Before 
use 12 % heat inactivated oestrus cow serum and FSH (10 µg/ml) were added. 
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Fertilization medium: The fertilization medium is a modified Tyrode-Solution (Parrish et 
al. 1988). Prior to fertilisation the medium is supplemented with 6 mg/ml BSA, 2.2 µg/ml 
sodium pyruvate, 2 µg/ml heparin, 12 µM hypotaurin and 1.2 µM epinephrin. 
 
Penicillin, hypotaurin, epinephrine (PHE) preparation:  
PHE is a combination of 3 different solutions. Solution 1 contains 0.9 % NaCl; in 
solution 2 1.1 mg hypotaurin is dissolved in 10 ml 0.9 % NaCl-solution. Solution 3 
contains 40 mg sodium dihydrogen sulphate, 100 µl 60 % sodium lactate solution and 
1.8 mg epinephrin, dissolved in 40 ml water. The three solutions are mixed, sterile 
filtered and store at – 20 °C.  
 
Capacitation medium: The capacitation medium is also a modified Tyrode-Solution 
(Parrish et al. 1988). Before use it is supplemented with 6mg/ml BSA, 110µg/ml 
sodium pyruvate and 2µg/ml heparin. 
 
Culture medium: The culture medium called CR1aa (Rosenkrans and First 1994) is 
supplemented with 10 % oestrus cow serum, 10 µl/ml minimal essential medium 
(MEM) and 10 µl/ml basal medium eagle (BME) prior to use. 
 
3.1.2 Reagents and other media  
 
All solutions used in this investigation were prepared with deionized and demineralized 
(Millipore) water and pH was adjusted with Sodium hydroxide or Hydrochloric acid. 
The chemicals, reagents, kits and buffers used in this study are given below.  
 
Amersham, Biosciences (Freiburg, Germany): ECL Plus Western blot reagents, donkey 
anti-rabbit antibody 
Biomol (Hambourg, Germany): Phenol, Lambda DNA Eco91I (BstE II) and Lambda 
DNA HindIII Anti-iNOS/NOS II (rabbit polyclonal IgG)  
Biozym Diagnostik (Hessisch-Oldendorf, Germany): Sequagel XR sequencing gel 
(National Diagnostics) and SequiTherm ExcelTMII DNA sequencing kit 
(Epicentre Technologies) 
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Dynal (Oslo, Norway): Dynabeads 
Gibco/BRL, Life Technologies (Karlsruhe, Germany): TrizolTM reagent and 
SuperScriptTMII reverse transcriptase  
MWG Biotech (Ebersberg, Germany): Oligonucleotide primers   
Promega (Mannheim, Germany): DTT, pGEM®-T vector, Pfu DNA polymerase and 
10x reaction buffer, 10 x BSA and 10 x buffer, Rnase free-Dnase, Rnasin 
Ribo-nuclease inhibitor, RQ1 Rnase-free Dnase and 10 x buffer, T4 DNA 
ligase and 2x rapid ligation buffer  
Qiagen (Hilden, Germany): RNeasy Mini Kit  
Roth (Karlsruhe, Germany): Acetic acid, Agar-Agar, Ampicilin, Ammonium 
peroxodisulpahte (APS), Boric acid, Bromophenol blue, Chlorofrom, 
Dimethyl sulfoxide (DMSO), dNTP, EDTA, Ethanol, Ethidiumbromide, 
Formaldehyde, Formamide, Glycerin, Hydrochloric acid, Hydrogen peroxide 
(30%), IPTG, N,N´-dimethylformamide, Nitric acid, Peptone, Proteinase K, 
SDS, Silver nitrate, Sodium carbonate, Sodium chloride, Sodium hydroxide, 
TEMED, Tris, X-gal, Xylencyanol, Yeast-extract and petridish plate (Ø = 9 
mm. and 12 x 12 mm.)  
Schleicher-Schuell GmbH (Dassel, Germany): Nitrocellulose Transfer Membrane, 
Whatman paper  
Sigma-Aldrich Chemie GmbH (Taufkirchen, Germany): Albumin bovine, 2,2´Azino bis 
(3-ethylbenzthiazo-line-6-sulphonic acid), Agarose, Anti-rabbit IgG (whole 
molecule) FITC conjugated, Blue dextran, Calcium chloride, Dulbecco’s 
phosphate buffered saline (DPBS), Ethylene glycol-bis (2-amino- ethylether)-
N,N,N´,N´-tetraacetic acid (EGTA), Polyvinylpyrolidone (PVP), Fetal calf 
serum (FCS), Glutamin, Isopropanol, Magnesium chloride, Oligonucleotide 
primers Penicillin, Rabbit anti-nitric oxide synthase-endothelial (eNOS) (569-
609), Streptomycin G, SYBR®Green JumpStart Taq ReadyMix, Taq 
polymerase, Triton X-100 (t-octylphenoxypolyethoxyethanol) and Tween-20. 
Stratagene (Amsterdam, Holland): 5α DH Escherichia coli competent cell and Lambda 
DASH II 
StressGen Biotechnologies Corp (Victoria, Germany): Rabbit Anti-NOS I polyclonal 
antibody  
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3.1.3 Buffers and solutions 
 
All solutions used in this investigation were prepared with deionized millipore water 
and pH was adjusted with sodium hydroxide (NaOH) or hydrochloric acid (HCl). 
Binding buffer: Lithium chloride (5 M) 1000 µl 
 Tris HCl (1 M pH 7.5) 10 ml 
 EDTA (0.005 M pH 8) 20 ml 
 Water  added to  50 ml and 
sterile filtered 
  
Blotting buffers: Anode buffer I Tris-HCl pH 10.4                  300 mM 
 Methanol   10 % 
                           Anode buffer II Tris-HCl pH 10.4                   25 mM 
  Methanol   10 % 
                          Cathode buffer   Tris-HCl pH 9.4                    25 mM 
 Methanol   10 % 
 6-aminohexanoic acid 60 mM 
  
Cytoskeleton buffer (CB buffer) Sodium chloride (150 mM/l)     0.438 g 
 Magnesium chloride (5 mM/l)   0.051 g 
 EGTA(5mM/l)      0.095 g 
 Glucose(5mM/l)      0.049 g 
 MES (10mM/l)pH 6.1     0.098 g 
 Water  added to       50 ml 
  
DEPC-treated water DEPC: 1 ml/L water incubate at 37 °C  
 overnight and inactivated by autoclaving 
  
Epinephrin solution Sodium disulphate    0.0400 g 
 Epinephrin   0.0018 g 
 Water  added to   40 ml 
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10 x FA buffer MOPS                           200 mM 
 Sodium acetate    50 mM 
 EDTA                10 mM 
 adjust pH to 7.0 
  
1.2 % FA buffer Agarose                        1.2 g 
 10 x FA buffer    10 ml 
 37 % formaldehyde      1.8 ml 
 Ethidium bromide      1 µl 
 fill up to 90 ml with depc water and boil 
  
IPTG (0.5 M): IPTG 000   1.2 g 
 Water added to                      10 ml  
  
LB-agar plate:  Sodium chloride 00  8 g 
 Pepton 00   8 g 
 Yeast extract 00  4 g 
 Agar-Agar 0   12 g 
 Sodium hydroxide, 1N  480 µl 
 Water added to            800  
  
LB-broth: Sodium chloride 00  8 g 
 Pepton 0   8 g 
 Yeast extract 00  4 g 
 Sodium hydroxide, 1N  480 µl 
 Water added to   800 ml  
  
Lysis buffer: Igepal     8 µl 
 Rnasin    5 µl 
 DTT    5 µl 
 Water     82 µl 
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Physiological solution: Sodium chloride   9 g 
 Water added to   1000 ml 
  
PHE medium: 0.9 % sodium chloride solution  16 ml 
 Hypotaurin solution        10 ml 
 Epinephrin solution 0       4 ml  
  
Propidium iodide(0.5µg/ml): stock 
solution 
Propidium iodide        1 mg 
 Added water to       5 m1 
  
Running buffer (10 x): Tris base (0.25M)   30.3 g 
 Glycin (1.92M)   144 g 
 SDS      10.0 g 
 Water added to    1000 ml 
  
Sample buffer (4 x): Tris 1M pH 6.8    13 ml 
 SDS     6 g 
 2-Mercaptoethanol   10 ml 
 Glycerine     20 ml 
 Bromophenol blue    10 mg  
 Water   added to    50 ml 
  
Separating gel (10 %): Water     4.25 ml 
 Acrymlamide bis 30/0.8 %  5 ml 
 Tris 1M pH 8.8    5.6 ml 
 SDS 10 %    0.15 ml 
 TEMED     0.010 ml 
 APS 20 %     0.030 ml  
  
Stacking gel (4 %): Water     7.15 ml 
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 Acrymlamide bis 30/0.8 %  1.5 ml 
 Tris, 1M, pH 6.8   1.3 ml 
 SDS, 10 %   0.15 ml 
 TEMED    0.010 ml 
 APS 20 %   0.030 ml  
  
Solutions for immunohistochemistry:  
Paraformaldehyde (16 %) stock solution PFA     1.6 g 
 added water to  10 ml 
PBS + polyvinyl alcohol (PVA) PVA     300 mg 
 added PBS to   50 ml 
Glycine-PBS (30 mmol/ml)  Glycine                        0.022521 g  
 added PBS + PVA solution 10 ml 
Permeabilization solution: Triton x-100    5 µl 
 added Glycine-PBS   10 ml 
Blocking buffer (3% BSA) BSA     0.15 g 
 added PBS + PVA   5 ml 
  
TAE (50x) buffer, pH 8: Tris 0    242 mg0 
 Acetic acid 00  57.1 ml  
 EDTA (0.5 M) 0  100 ml00 
 Water added to  1000 ml 
  
TBE (10x) buffer: Tris 0    108 g 
 Boric acid 00   55 g 
 EDTA (0.5 M) 00  40 ml 
 Water added to   1000 ml 
  
TE buffer: Tris (1 M) 00   10 ml 
 EDTA (0.5 M) 000  2 ml 
 Water added to   1000 ml 
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Washing buffer: Lithium chloride (5 M) 1500 µl 
 Tris-HCl (1 M pH 7.5) 500 µl 
 EDTA (0.005 M pH 8) 1000 µl 
 Water added to 50 ml and filtered 
  
X-gal: X-gal 00   50 mg 
 N, N´-dimethyl-formamide 0 1 ml  
 store at – 20 °C 
 
3.1.4 Equipments 
 
ABI Prism Sequence Detection System Instrument: ABI, Forster City, CA, USA 
Automated sequencer (LI-COR 4200):  MWG Biotech, Ebersberg, Germany 
Centrifuge:     Hermle, Wehingen, Germany 
Carbon dioxide incubator (BB16):   Heraeus, Hanau, Germany 
Carbon dioxide incubator (MCO-17AI):  Sanyo, Japan 
CLSM LSM 510:    Carl Zeiss, Germany 
Electrophoresis (for agarose gels):   BioRad, München, Germany 
Fluorescence microscope (DM-IRB): Leica, Bensheim, Germany 
PCR thermocycler (PTC100):   MJ Research, USA / BioRad, Germany 
Power Supply PAC 3000:    BioRad, München, Germany 
Power Supply Mini-ProtanR:    BioRad, Italy 
Spectrophotometer (DU-62):   Beckman 
UV Transilluminator (Uvi-tec):   Uni Equip, Martinsried, Germany 
Videocamera (TK-C1306BE):  JVC, Japan 
 
3.1.5 Software programms  
 
BLAST programm:    http://www.ncbi.nlm.nih.gov/blast/  
Multiple sequence alignment: http://prodes.toulouse.inra.fr/multalin/multalin.html 
Automated sequencer: Li-COR, MWG-Biotechnology, USA 
Primer design:   Primer Express Software -ABI prism version 2.0 
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SAS version 8.0:   SAS Institute Inc., Cary, NC 
Image analysis:  Bio-Rad Laser- Sharp MRC-1024 CLS software 
 
3.1.6 Biological material  
 
Bovine ovary, follicle, granulosa cells and in vitro produced oocytes and embryos were 
used in this work. 
 
3.2 Methods  
 
The overview of the methods used in the present study is given in figure 8 below. 
 
 
 Bovine ovary, follicle, granulosa cells, oocytes and embryos 
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3.2.1 Biotechnology methods 
 
All techniques used in bovine in vitro embryo production will be described in this 
section. 
 
3.2.1.1 Oocyte collection and maturation 
 
The ovaries obtained from local slaughterhouse were washed with 70 % ethanol and 
two times with 0.9 % physiological saline solution (both solutions warmed at 30 °C). 
The follicles with a diameter of 1 to 8 mm were punctured using a sterilised 5 ml 
syringe attached to a 20 G needle (0.9x40). The follicular liquid was collected in 
sterilized 15 ml tube warmed at 30°C and left stand for 15 minutes to sediment or 
centrifuged. The oocytes surrounded by cumulus cells were collected under the 
microscope in the modified parker medium. After three times of washing counted oocytes 
(50 oocytes/well) were transferred in 400 µl maturation medium smeared with mineral 
oil (Sigma) in four well dishes (Nunc, Roskilde, Denmark). Maturation was performed 
in an incubator at a temperature of 39 °C and an atmosphere of 5 % CO2 for 22-24 h.  
 
3.2.1.2 In vitro fertilization 
 
Two sperm straws were thawed at a temperature of 39 °C for 8 seconds in a water bath, 
and separated by means of the “swim up” technique in capacitation medium in the 
incubator for 50 minutes (Parrish et al. 1988). The supernatant was carefully discarded 
away and the sperms were resuspended in 3.5 ml capacitation medium, centrifuged at 
250 g for ten minutes with discarding the supernatant. The sperm were diluted and 
counted in a haemocytometer. The matured oocytes in group of 50 were transferred in 
fertilization medium: Fert-TALP (Parrish et al. 1988) fertilized at 1x106 spermatozoa/ml 
and incubated for 18 h. 
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3.2.1.3 In vitro culture 
 
Following fertilization, zygotes were treated with 0.1 % (w/v) hyaluronidase and 
vortexing for approximately 5 minutes, to remove the cumulus cells. Cumulus free 
zygotes were washed and transferred to CR1aa media (Rosenkrans and First 1994) 
supplemented with essential and non essential amino acids. Further culture in cuture 
medium was performed in the same incubator in the same conditions as used for 
maturation and fertilization.  
 
3.2.1.4 Nitric oxide inhibition and embryo development study 
 
In order to investigate the effect of NO inhibition in early development three doses of L-
NAME (0.1 mM, 1 mM and 10 mM) were applied in either only maturation or culture 
medium and in both maturation and culture media. Controls with no L-NAME addition 
were run along with all treatment groups. All experiments were repeated at least three 
times each comprising 200 oocytes for maturation and subsequent culture.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IVM IVC
     0 hpi    24 hpi 48 hpi        168 hpi     192 hpi   216 hpi
IVF 
Monitoring embryo development 
(Cleavage and blastocyst rate) 
L-NAME addition (0 mM, 0.1 mM, 1 mM and 10 mM) 
Figure 9:  Experimental design to assess the effect of addition of L-NAME (0 mM, 
0.1 mM, 1 mM and 10 mM) either to the maturation or culture or both 
media on the cleavage and blastocyst rates in vitro fertilized oocytes. 
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Experiment 1. Four groups of immature oocytes (50 oocytes in each group) were 
incubated in the maturation media to which 0, 0.1, 1 and 10 mM L-NAME was added 
then omitted in the further fertilization and culture of the oocytes.  
 
Experiment 2. Here also four groups of immature oocytes were allowed to mature in the 
absence of L-NAME. Following maturation, oocytes were co-incubated with bull 
spermatozoa zygotes for 20 h and transferred to wells containing culture medium to 
which 0, 0.1, 1 and 10 mM L-NAME were added.  
 
Experiment 3. Equal groups and numbers of immature oocytes as used in experiment 1 
and 2, were allowed to mature in the maturation media to which 0, 0.1, 1 and 10 mM L-
NAME was added and fertilized in the absence of the inhibitor. Presumptive zygotes 
were further cultured in media which was supplemented with the corresponding dosages 
of L-NAME.  
 
As indicated in the figure 9 above, during this experiment embryo development in vitro 
culture was assessed by determining the cleavage rate at 48 hpi and the blastocyst rate at 
days 7 (168 hpi), 8 (192 hpi) and 9 (216 hpi).  
 
3.2.1.5 Statistical analysis 
 
Data from a minimum of three repeats were analysed using one-way ANOVA and the 
Tukey test. The statistical model includes glm and the Tukey test was used to appreciate 
the difference in proportions of embryos at the appropriate stage of development in the 
control embryos versus those cultured in NOS inhibitor (L-NAME). Differences were 
considered significant if p ≤ 0.05. 
 
3.2.2 Molecular genetics methods 
 
General methods of molecular genetic analysis as used in this study are described in the 
following section  
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3.2.2.1 RNA isolation  
 
Messenger RNA was isolated from pooled frozen bovine embryos of immature 
oocytes, mature oocytes, 2-cell stage (2C), 4-cell stage (4C), 8-cell stage (8C), morulae 
(Mor) and blastocyst (Bl) using oligo (dT)25-attached magnet beads Dynal® according to 
the manufacturer indications. It is based on the pairing between the polyA tail of most 
mRNA and the oligo dT sequences bound to Dynabeads surface. Embryos were lysed in 
30 µl binding buffer at 70 °C for 5 minutes and cells lysat was mixed with a prewashed 
Dynabeads. The lysate mixed with Dynabeads, was kept for 30 min to anneal at room 
temperature. The mRNA attached to Dynabead was washed twice with 150 µl washing 
buffer, 12 µl ddH2O added and denatured at 90 °C for 5 minutes. After short centrifuge 
the eluate (mRNA) was taken in new sterile labelled tubes and store at – 20 °C for 
further use. The RNA samples were checked for DNA contamination if there is any by 
PCR amplification with β-actin gene primers: (forward: 5´-GAGAAGCTCTGCTACGTCGA-
3´ and reverse: 5´-CAGACAGCATGTTGGC-3´) using standard protocols before cDNA 
synthesis. 
Total RNA was extracted from frozen bovine ovary, follicle and granulosa cell 
using TRIzol reagent. Some milligrams (30-50) of tissue were ground into powder in a 
prechilled mortar, resuspended in digestion buffer: TRIzol® reagent (Life Technologies) 
in a volume of 1 ml homogenised with syringe and needle and incubated 5 min at RT. 
The samples were mixed with 0.2 ml chloroform vigorously shaken with hand for 15 
sec and left 2-3 min at RT. The mix is centrifuged at 1200 x g for 15 min at 2-8 °C. The 
upper aqueous phase containing RNA was transferred in new 2 ml tube mixed with 0.5 
ml isopropanol and allowed to precipitate at RT for 10 min. After centrifugation, the 
RNA precipitate visible as white pellet was collected by draining the supernatant off. 
The pellet was once again washed with cold ethanol (75 %), then removed and RNA 
briefly dried at air for 10 min. The RNA was dissolved in 20 µl RNase-free water.  
To remove eventual residual DNA, the RNA was submitted to DNase. The RNA was 
mixed with 1µl RNasin, 4µl of RQ1 buffer, 7.5 µl of RQ DNase I, made up to 40 µl 
final volume with RNase-free water then incubated at 37 °C for 1h. Once DNA digested 
the RNA was purified with RNeasy Mini kit for RNA clean up (Qiagen) according to 
the manufacture’s instruction. The integrity of the RNA was checked by electrophoresis 
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on 1.2 % FA gel at 120 volts for 15 min. The concentration (ng/µl) was determined by 
measuring the OD at 260 and 280 for the ratio OD260/280 and calculated as 40 x OD260 x 
dilution factor. The stock RNA solution was stored at – 80 °C until use.  
 
3.2.2.2 cDNA synthesis 
 
The first strand cDNA was synthesized from both the messenger and total RNA. Eleven 
(11) µl of mRNA was mixed with 100 µM Oligo dT (11) N (5´-TTTTTTTTTTTN-3´) 
primer in 12.4 µl volume.  This mixture was heated at 70 oC for 3 minutes and cooled to 
0 oC for 2 minutes. Then 4 µl of 5 x First-Strand Buffer (GibcoBRL), 2 µl of DTT (0.1 
M), 1 µl of 10 mM dNTP, 0.1µl Rnasin and 0.5 µl of SuperScriptII RNase H- reverse 
transcriptase (200 units/µl, GibcoBRL) were added. This reaction was incubated at 42 
oC for 90 minutes and the reverse transcriptase was deactivated by heating at 72 oC for 
15 minutes. The first strand cDNA reaction was diluted or not and kept at -20 oC for the 
subsequent use. 
The synthetized cDNA was tested by amplifying a portion of histone 2a gene using 
standard PCR conditions. Amplification of 2 µl of cDNA was performed with Taq 
polymerase (Sigma) in a final reaction volume of 20 µl, containing 0.5 µl of dNTPs (10 
mM), 0.5 µl of each of primers at 10 µM (forward: 5´-CTCGTCACTTGCAACTTGCTATTC-
3´ and reverse: 5´-CCAGGCATCCTTTAGACAGTCTTC-3´) in 1 x PCR buffer in thermal 
cycler for 35 cycles at 95 oC denaturation, 60 oC annealing and 72 oC extension 
followed by 5 minutes extension at 72 oC. Finally, products were visualized on a 2 % 
agarose gel. 
 
3.2.2.3 Nitric oxide synthase genes primer design 
 
The PCR primers were based on the bovine nitric oxide synthase (eNOS and iNOS) or 
human (nNOS) EST sequences using Primer Express Software (version 2.0, ABI) and 
were as shown in table 3.1. The specific primers were obtained by exclusion of 
conserved sequence using multiple sequence alignment programm: 
http://prodes.toulouse.inra.fr/multalin/multalin.html 
 
 
Materials and methods   45
Table 3.1: List of specific primers used in this study 
Gene GeneBank 
Acc. No 
Primer sequence (5´- 3´) Product  
size 
(bp) 
Annealing  
temperature 
(°C) 
 Qualitative PCR   
eNOS M95674 For-TTCCCAGAGACTGTTGGATTCC 
Rev-ACCTAAACACCAAAGGGCTGAC 
137 60  
iNOS AF340236 For-ATCTTCGCCACCAAGCAG 
Rev-ACCTGATGTTGCCGTTGTTG 
167  60  
GAPDH BTU85042 For-ACCCAGAAGACTGTGGATGG 
Rev-ACGCCTGCTTCACCACCTTC 
247 62  
 Quantitative real time PCR   
iNOS AF 340236 For-GGTGGAAGCAGTAACAAAGGA 
Rev-GACCTGATGTTGCCGTTGTTG 
230 50-56  
eNOS NM_181037 For-CCTCACCGCTACAATATCCT 
Rev-TGCTCGTTGTCCAGGTGCTTC 
197 50-56  
nNOS HSNOS1S1 For-CGTCTCTTCAAGCGCAAAGTT 
Rev-CGTTGACCGCAAGAATGATGT 
151 43-49  
H2a NM_178409 For-CTCGTCACTTGCAACTTGCTATTC 
Rev-CAGGCATCCTTTAGACAGTCTTC 
148 60  
 
3.2.2.4 Polymerase chain reaction (PCR)  
 
PCR amplification was performed in 20 µl reaction volume in 1 x PCR buffer (Pfu 
DNA polymerase, Promega), containing 2 µl of embryo cDNA templates or 50 ng/µl 
genomic DNA, 0.5 µl of each primer (10 µM), 0.5 µl of dNTP (50 µM), and 0.5 U of 
Taq polymerase (Pharmacia or Sigma). The PCR reactions were carried out in a PT-100 
Thermocycler (MJ Reasearch) and the thermal cycling program was: denaturation at  
94 oC for 4 min, followed by 35 cycles at 94 oC for 30 sec, annealing at the 
corresponding temperature (as shown in table 3.1) for 30 sec and extension at 72 oC for 
1 min, final extension step at 72 oC for 5 min. The PCR product was subjected to 
electrophoresis with a lambda DNA BstEII marker as a reference for fragment size. The 
gel was photographed under UV- transilluminator. 
3.2.2.5 DNA extraction from agarose gel 
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The amplified products were electrophorosed in 0.7-1 % agarose gel having large 
combed well. The product was visualized under UV transilluminator and the gel having 
the DNA fragment of interest was cut and DNA isolated by phenol-chloroform 
extraction method. The gel was homogenized in 0.5 ml of 1 x TE buffer, mixed with 0.5 
ml of phenol-chloroform and centrifuged at 10,000 rpm for 20 minutes. The supernatant 
was transfered to a new tube and 0.5 ml of chloroform added, mixed thoroughly and 
centrifuged at 10,000 rpm for 20 min. The DNA was precipitated with double the 
volume of chilled absolute alcohol after adding 1/20th volume of 3 M sodium acetate 
(60 µl) and stored at –20 oC overnight. The extracted DNA was washed with 70 % 
alcohol, dried at air and dissolved in 6 - 8 µl of distilled water for further used. 
 
3.2.2.6 Cloning and sequencing of PCR fragments 
 
Ligation  
 
The ligation reaction was setup in a PCR tube as follows: 2.5 µl of 2 x Rapid ligation 
buffer, 0.5 µl of pGEM®–T vector (50 ng / µl) (Promega), 0.5 µl of T4 DNA ligase (3 
Units / µl) and 1.5 µl of template DNA were added and mixed by pipetting. The 
reaction was incubated overnight at 4 oC. 
 
Transformation 
 
The tubes containing the ligation reaction were spinned briefly to collect the contents at 
the bottom of the tube. About 3.5 µl of each ligation mixture was added to a sterile 15 
ml tube, kept in ice. The competent cells (JM109 Strain or DH5α strain of E. coli) for 
transformation were removed from -80 °C just prior to adding and thawed by placing in 
ice. After gently flicking the tube, sixty (60) µl of competent cells was transferred into 
the 15 ml tube and incubated along with 3.5 µl of ligation mix on ice for 30 minutes. 
Then, the competent cells were heat shocked at 42 oC for 90 seconds in a water-bath and 
immediately cooled on ice for 2 minutes. Finally 650 µl of LB broth was added and 
incubated at 37 oC in shaking incubator for 2 h. 
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Cloning and screening of the transformants 
 
Two LB/ ampicillin/ IPTG/ X-gal plates for each ligation reation waere prepared by 
adding 20 µl of 0.1 M IPTG and 20 µl of X-gal (50 mg/ml) to the LB plates with 
ampicillin and spread with a glass spreader (20 minutes prior to use). The 
transformation culture was plated to LB/ ampicillin/ IPTG/ X-gal plates in duplicate and 
incubated at 37 oC overnight until colonies are visible.  
Successful cloning of an insert in the pGEM-T vectors interrupts the coding sequence of 
β-galactosidase, hence the vectors with insert produce white colonies in plate against 
blue colony which doesn’t have inserts. Two white colonies and a blue colony (negative 
control) are picked in 30 µl of 1 x PCR buffer, from each plate. The bacteria were lysed 
by heating at 95 oC for 15 minutes. The colonies were screened for the insert by 
performing a PCR with primers designed in M13 promoter region of the vector.  
M13 PCR has been done to confirm transformation success and identify the clones with 
insert. 20 µl of reaction volume containing 10 µl of lysate, 0.5 µl dNTPs (10 mM), 0.5 
µl of each of primers (forward: 5´-TTGAAAACGACGGCCAGT-3´, reverse: 5´- 
CAGGAAACAGCTATGACC-3´), 0.5 U of Taq polymerase (Sigma) in 1 x PCR buffer were 
amplified in PTC 100 (MJ Research) thermal cycler for 35 cycles at 95 oC denaturation, 
60 oC annealing and 72 oC extension followed by 10 minutes of final extension at 72 oC. 
The products were electrophoresed in 2 % agarose gel. Clones having insert would be 
having higher molecular weight fragments than the blue clones. 
 
Sequencing 
 
The positive clones were sequenced by using LI-COR automated DNA sequencer. The 
sequencing is carried out by dye termination method using a SequiTherm Excel TM II 
DNA sequencing Kit (Epicentre Technologies, Biozyme). For each sample, 4 reactions 
were performed, each reaction having one dideoxy nucleotide termination mix (ddATP, 
ddTTP, ddCTP and ddGTP) which will terminate the elongation reaction once the 
nucleotide binds to the elongating strand. The primers used were designed from Sp6 (5´-
TAAATCCATGTGTATCTTATG-3´) and T7 (5´-ATTATGCTGCTGAGTGATATATCCCGCT-3´) 
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promoter regions of the pGEM-T vector and is flourescent labelled which can be laser 
read by LI-COR automated DNA sequencer. Each reaction consists of 1µl of 
termination mix and 2 µl of premix solution (3.6 µl of sequencing buffer, 0.8 pM of 700 
IRD-labeled SP6 primer, 0.8 pM of 800 IRD-labeled T7 primer, 1.5 µl of M13 PCR 
product and 2.5 U Taq polymerase). PCR was performed in a thermal cycler (MJ 
Research) for 29 cycles with 95 oC denaturation, 59 oC annealing and 72 oC extension, 
followed by 5 minutes last extension at 72 oC. Immediately after PCR, 1.5 µl of stop 
buffer was added and the product was stored at –20 oC till loading. Before loading, the 
sequencing reactions were denatured at 95 oC for 5 minutes and loaded onto 41 cm 6 % 
Sequagel-XR (National Diagnostics, Biozyme). Electrophoresis was performed on a LI-
COR model 4200 automated DNA sequencer in 1x TBE buffer at 50 oC, 50 W and 1500 
V.  Sequence data was analysed by using Image Analysis programm, version 4.10 (LI-
COR Biotechnology). 
 
3.2.3.7 Plasmid isolation 
 
Plasmid DNA containing the insert of each of the isoform should be isolated to be used 
as standard for real-time PCR assay. The PCR products were amplified using the above 
mentioned primers covering the isoform specific site and cloned in pGEM-T vector. The 
positive colonies were cultured overnight at 37 oC in a 5 ml LB broth containing 
ampicillin. The recombinant E. coli cultures were pelleted by centrifuging at 12,000 rpm 
for 1 minute. Plasmid DNA was isolated by using the GenElute plasmid Miniprep Kit 
(Sigma), following the manufactures instructions. Briefly, the cells were resuspended 
with 200 µl of the resuspension solution, mixed thoroughly by vortexing and the cells 
were lysed by incubating with 200 µl of lysis solution for 4 minutes. The cell debris were 
precipitated by adding 350 µl of Neutralization or binding buffer and centrifuged at 
12,000 rpm for 10 minutes. In the mean time, columns were prepared by using column 
preparation solution. The cleared lysate were added to the prepared column and 
centrifuged at 12,000 rpm for 1 minute and the flow through was discarded. The column 
were again washed with 750 µl of wash solution and centrifuged at 12,000 rpm for 1 
minute and the flow through was discarded. Finally the plasmid DNA was eluted by 
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adding 100 µl of distilled water and eluted by centrifugation. The isolated plasmid DNA 
was sequenced to confirm the presence of the specific isoform. 
 
3.2.3.8 Plasmid serial dilutions 
 
The concentration of the plasmid DNA was estimated by reading the absorbance at 260 
nm (A260) in a spectrophotometer UV/visible light (Beckman DuR 62). The plasmid 
concentration (ng/µg) = A260 x dilution factor x 50, was converted in number of copies 
(molecules) using the following program: www.molbiol.ru. The plasmid DNA was 
diluted to be similar to the concentration of the target in the embryos. Then serial 
dilutions were prepared for each EST from 101 up to 108 copy number in 45 µl volume. 
 
3.2.3 Real-time quantitative PCR 
 
In order to monitor gene expression, we used real-time RT-PCR analysis. Real time 
PCR was performed using mRNA, isolated from pooled oocytes and embryos, with 
SYBR® Green (Sigma) in an ABI prism 7000 SDS instrument (Applied Biosystems, 
USA). The amount of transcript in a sample is estimated as a function of how a 
fluorescent signal is observed above threshold (CT value) during the process of 
sequence amplification. The threshold cycle (CT) is the point at which the fluorescence 
signal is first recorded as statistically significant above the background. During every 
cycle the fluorescence values are recorded and represent the amount of the product 
amplified to a precise time. The correlation is the more a template present at the 
beginning; the fewer number of cycles are needed to reach the CT point.  
 
3.2.3.1 Optimization of the PCR conditions 
 
SYBR Green binding dye was used to generate fluorescence as a function of 
temperature to perform a melting or dissociation curve of the amplicon which is 
sequence specific. A dissociation curve is produced by monitoring fluorescence 
continuously while heating the sample in order to observe the loss of fluorescence at the 
denaturation temperature. Single strong pick represent single PCR product whereas two 
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or more peaks indicate multiple PCR products. As the product specificity is determine 
by its primer, a prerequisite optimizing step was done.  
SYBR®Green JumpStartTM Taq ReadyMixTM with internal reference dye for 
quantitative PCR (Sigma) combining non-specific product formation prevention to 
reaction normalization was used. PCR was performed in ABI prism 7000 sequence 
detection system. PCR condition is 50 oC for 1 sec, 95 oC for 10 min followed by 40 
cycles of 95 oC for 15 sec and 60 oC for 1 min.  
The specificity of the target quantification is reached by determining the minimum 
primers concentrations which give the lowest threshold value and minimizing non-
specific amplification. Analysis of the dissociation curve to check the absence of non-
specific product was confirmed by agarose gel electrophoresis. The optimum 
combination was selected for use as standard primer concentration for further steps. 
 
3.2.3.2 Quantification: precision/reproductibility of the replicates 
 
A standard curve was generated for each isoform by amplifying the serial dilutions of 
the known quantities of plasmid DNA (101-108 molecules). Precision and 
reproducibility are important in any quantification system and can be measured through 
the replicates (technical and biological replicates). In this work the primers were tested 
in identical duplicates using the same pool preparation with the same PCR reagents for 
each fragment.  
Each reaction was performed in 20 µl containing 2 µl cDNA, optimal up and down 
stream primers, SYBR®Green JumpStartTM Taq ReadyMixTM (Sigma) and water. 
To measure expression levels accurately, normalization by multiple housekeeping genes 
instead of one is required (Vandesompele et al. 2002); but it is generally accepted that 
gene-expression levels could be normalized by a carefully selected stable internal 
control gene. Indeed the internal control should not change in relative abundance during 
the course of treatments or investigation (Suzuki et al. 2000). Over eight housekeeping 
genes RNA levels quantified using real time PCR, histone 2a was the best internal 
standard in preimplantation period of bovine embryo (Robert et al. 2002). Final 
quantification analysis was done using the relative standard curve method (User bulletin 
# 2 ABI PRISM 7700 SDS) and results were reported as the relative expression (RE) or 
 
Materials and methods   51
n-fold difference to the calibrator cDNA (i.e. the sample with the lowest normalized 
quantity) after normalization of the transcript amount to the endogenous control. 
 
3.2.3.3 Statistical analysis 
 
Data of mRNA expression were analysed using one-way ANOVA followed by the 
Tukey test. Differences were considered significant if p ≤ 0.05. 
 
3.3 NOS proteins detection and localization in bovine oocytes and embryos 
 
The elucidation of specific temporal and spatial protein localisation in early embryos is 
a key prerequisite for understanding development (Kurth 2003). However it is not easy 
to obtain protein localisation data from whole embryos with adequate resolution. In this 
section, NOS proteins localization using immunofluorescence will be described.  
 
3.3.1 Immunohistochemistry  
 
Immunohistochemistry is the localization of antigens in tissue by the use of labelled 
antibodies as specific reagents through antigen-antibody interactions that are visualized 
by a marker such as fluorescent dye, enzyme, and radioactive element. 
 
Direct or indirect method  
 
Direct method is one step staining method, and involves a labelled antibody reacting 
directly with the antigen in tissue. Indirect method involves an unlabelled primary 
antibody which reacts with tissue antigen and a labelled secondary antibody reacts with 
primary antibody. This method is more sensitive due to signal amplification through 
several secondary antibody reactions with different antigenic sites on the primary 
antibody. The second antibody may be labelled with a fluorescent dye such as FITC, 
Rhodamine or Texas red and is called indirect immunofluorescence method. Indirect 
immunoenzyme method design the second antibody labelled with an enzyme such as 
peroxidase, alkaline phosphatase or glucose oxidase. 
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Fixation and blocking 
 
Fixation is the critical step in the preparation of histological specimens (Kurth 2003). 
For immunocytochemistry, fixation has to yield preservation of the structure and 
antigenicity. To ensure the preservation of cell morphology, adequate fixation is 
essential. In fact, inappropriate or prolonged fixation may significantly diminish the 
antibody capability. Background staining may be specific or non-specific. Inadequate or 
delayed fixation may give rise to false positive results due to the diffusion of the 
antigen. Antibodies, (especially polycolonal antibodies) are sometimes contaminated 
with other antibodies and this will lead to the background staining in cell or tissue 
sections. Using higher antibody dilution might be helpful to reduce the background. 
 
Confocal laser scanning microscope principle 
 
Observing thickbiological specimens using a conventional light microscope is often an 
unrewarding experience: structures above and below the plane of focus being examined 
usually badly obscure the image (White and Dixon 2003). The last decade confocal 
imaging has gained favour as a method for fluorescence microscopy, allowing direct 
visualisation within thick, fluorescently labelled tissue. The big advantage of confocal 
microscopy is the possibility to collect light exclusively from a single plane. The laser 
scanning microscope scans the sample sequentially point by point, line by line and 
assembles the pixel information to one image with high contrast and resolution.  
 
3.3.2 Immunofluorescence  
 
3.3.2.1 Pre-treatment of samples 
 
Oocytes and embryos were washed three times in PBS, fixed in freshly prepared 4 % 
(w/v) paraformaldehyde in PBS overnight at 4 °C. The fixed specimens were washed 
twice in (0.3 mmol/l) glycine-PBS supplemented with PVA then permeabilized by 
incubation in PBS containing 0.5 % (v/v) Triton-X100 for 2h30min at RT. Non-specific 
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immunoreactions were avoid by incubating oocytes and embryos in 3 % (w/v) BSA 
freshly added in PBS plus PVA for 1h and then washed three times in PBS solution.  
 
Table 3.2: Daily working solutions  
Paraformaldehyde 4 % 250µl stock solution +750 µl CB buffer 
Glycine-PBS 0.3 mmol/l 100µl stock solution + 9.9 ml PBS/PVA 
Propidium iodide 0.5 µg/ml 1µl stock solution + 399 µl PBS/PVA 
Antibody Dilution 
Endothelial NOS 1 : 200 
Inducible NOS 1 : 80 
Anti-rabbit FITC conjugate 1 : 500 
 
3.3.2.2 Incubation with specific NOS antibodies 
 
Aliquoted antibody was removed from -20 °C, thawed and diluted (table 3.2) at the 
corresponding factor (determined after a serial dilution) in BSA solution shortly before 
use. Indeed BSA treatment reduces non-specific binding reactions. In drops (100 µl) of 
prepared primary (NOS) antibody in a 96 well petri-dish smeared with mineral oil the 
embryos were kept at 39 °C in incubator without CO2 for 1h. The specimens were 
washed three times 10 min each in PBS. Omitting primary antibody treatment before 
incubation with secondary antibody was used to determine the specificity of the first 
antibody. 
 
3.3.2.3 Identification of antigen-antibody complex by FITC secondary antibody 
 
Antigen-antibody recognition was made possible with help of fluoroscein 
isothiocyanate (FITC) conjugated to anti-rabbit antibody. Fluorescein is a small organic 
molecule, conjugated to proteins via primary amines (lysines), excited by the 488 nm 
line of an argon laser, and emission is collected at 530 nm. As for the primary antibody, 
prior to use the aliquot of secondary antibody (anti-rabbit immunoglobulin antibody 
conjugated to FITC) was diluted in BSA solution (table 3.2). The embryos are incubated 
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in 100 µl of prepared antibody smeared with mineral oil at 39 °C for 1h in dark. They 
were washed three times 10 min. each in PBS again.  
 
3.3.2.4 Propidium iodide staining 
 
In order to visualize cell nucleus propidium iodide was use in this section. Propidium 
iodide stain is an intercalating dye that appears red at 488 nm and used in flow 
cytometry to analyze cellular DNA content. The samples were incubated in well 
containing propidium iodide (0.5 µg/ml) for 25 min in dark at RT. 
After an ultimate three times wash in PBS the embryos were mounted on slides 
(SuperFrostRPlus, Braunschweig, Germany) in a drop of Vectashield mounting medium 
(VectorR) protected by cover slip sealed with nail polish, stored at 4 °C till microscopic 
analysis as fast as possible to reduce any fluorescence damage. 
 
3.3.2.5 Image capture and analysis 
 
Fluorescence of FITC was visualized by excitation at 488 nm with the argon laser on a 
confocal laser scanning microscope (CLSM LSM-510; Carl Zeiss, Oberkochen) 
equipped with Bio-Rad Laser-Sharp MRC-1024 confocal laser scanning software. 
Immunohistochemistry approach to analyse protein localization, in order to gain a 
comprehensive understanding of complex cellular processes and pathways could be 
confirmed by western blot analysis which is described in the following section. 
 
3.4 Nitric oxide synthase proteins immunoblotting  
 
Western blot analysis can detect one protein in a mixture of any number of proteins 
while giving information about the size of the protein. It does not matter whether the 
protein has been synthesized in vivo (native) or in vitro (recombinant). This method is 
however, dependent on the use of a high-quality antibody directed against a desired 
protein. Western blotting tells how much protein has accumulated in cells but if a 
protein is degraded quickly, western blotting won't detect it well. 
3.4.1 Protein isolation 
 
Materials and methods   55
 
Sample buffer with loading buffer (26 % of Tris 1M pH 6.8, 12 % of SDS, 20 % of 2-
Mercaptoehtanol and 40 % of Glycerol) was used to lyse cells (causes cell membranes 
to break and proteins to be released into buffer). Protease inhibitor cocktail (Sigma) was 
used to stop protease enzymes from denaturing proteins. Protease, if not inhibited, 
would be released as the cell was lysed and catalyzes the splitting of interior peptide 
bonds of proteins. Tissues or embryos samples were homogenized in sample buffer then 
centrifuged 10 minutes at 4 °C. The supernatant was collected after heating the 
homogenate at 95 °C for 5 min and stored at – 80 °C to avoid any denaturation till use. 
 
3.4.2 Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE)  
 
Sodium dodecyl sulphate (SDS) is an anionic detergent which denatures proteins by 
"wrapping around" the polypeptide backbone, confers a negative charge to the 
polypeptide in proportion to its length. The SDS-PAGE was performed according to 
Laemmli (1970): 4 % stacking gel plus 10 % separating gel. Separating gel is used to 
separate proteins into their respective sizes allowing sharp bands to be seen whereas the 
stacking gel organize proteins before they enter the separating one. 
To prepare a gel properly two gel glasses were cleaned thoroughly using soap and 
distilled water, assembled with space maker and water was added to test the porosity 
then dried. The separating gel (3.6 ml) was poured into the gel glass; the remainder of 
the space was filled with isopropanol to ensure that no air bubbles would form at the 
surface of the gel during gel polymerisation (5-10 minutes). The isopropanol was 
poured out, the gel dried with filter paper before adding the stacking gel on top of the 
separating one. A comb was inserted between gel plates and the gel polymerised at RT. 
In between the heater was set at 95 °C and proteins were warmed 5 minutes. 
A standard vertical gel electrophoresis apparatus was used to enable the loading of 
protein homogenate by adding 5 to 10µl of sample to the wells of the gel. One lane was 
reserved for 5 µl of a molecular marker solution (to compare with proteins in gel to 
determine their size). The gel was placed in an electrophoresis unit that was filled with 
one time running buffer and run at 200 mA until the bromophenol blue reach the bottom 
of the gel.  
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3.4.3 Semi dry blotting and blocking 
 
Nitrocellulose transfer membrane poresize 0.45 µm (Protan®, Schleicher and Schuell, ), 
nine pieces of filter paper Whatman (Schleicher and Schuell) by sample in size of 
6.5/8.5cm were soaked in water and blotting buffers (I, II, III) respectively for 
approximately 20 min before use. The transfer "sandwich" was assembled in the Trans-
Blot® SD Semi-Dry-Transfer Cell (Bio-Rad, USA). Time of transfer was 1h at 1.75 
mA/cm2 of gel. After the transfer was complete, the nitrocellulose blot was washed 
shortly in water and subsequently stained with 2 % Ponceau in 10 % acetic acid for 
approximately 5 min or until molecular molecular marker: PageRuler Prestained Protein 
Ladder (Fermentas, Life Sciences, France) bands appeared. The nitrocellulose blot was 
washed in TBST shortly and incubated in 1% polyvinyl pyrolidone (PVP) diluted in 
TBST at RT for 30 min to 1h on an orbital shaker to prevent the non-specific adsorption 
of the immunological reagents.  
 
3.4.4 Immunodetection (antibody affinity) 
 
The nitrocellulose blot was incubated in specific (anti-NOS) primary antibody diluted 
(1: 10000) in TBS supplemented with 0.1 % PVP overnight in the refrigerator at 4 °C. 
To prevent non-specific binding of primary and secondary antibody and reduce 
background of the blot, the nitrocellulose membrane was washed with 0.05 % (v/v) 
Tween-20 Tris buffer saline at room temperature (six times for 10 min each) on an 
orbital shaker. The second antibody anti-rabbit horsreddish peroxidase conjugated was 
diluted in the 0.1 % PVP (1:10000) and incubated with the blot for 1h at room 
temperature with agitation. At the end the membrane was washed six times 10 min 
each. 
 
 
 
3.4.5 Bands identificafion 
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The enhanced chemilumnescence (ECL) prepared solution for detection consists of 
ECL plus western blotting detection reagent A and B (40:1) from Amersham 
(Biosciences). After removing excess buffer from the membrane (by draining the 
membrane over a piece of folded paper and briefly touching the edge of the membrane 
to the paper) mixed ECL solution was added for 5 minutes incubation time. Once the 
solution removed, the membrane was taped to the inside autoradiography film cassette. 
In the dark, a sheet of x-ray film was added to the cassette then exposed to the 
membrane for impregnation and developed, then washed and fixed. In fact horsereddish 
peroxidase reacts with the substrate acridinium, resulting in a light emission by 
exposure to autoradiographic film (KodackR Biomax XAR film, Kodak, Japan). 
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4 Results 
 
4.1 Nitric oxide and bovine embryo development in vitro 
 
The effects of the NOS inhibitor L-NAME, was examined to investigate the role of 
NO/NOS activity in the development of bovine embryos in vitro during the 
preimplantation period. The in vitro development of bovine embryos was monitored 
daily at day 2 for cleavage rate, day 7 and day 9 during culture for blastocyst rate in 
medium with or without L-NAME at different concentrations.  
 
Experiment 1: L-NAME addition in maturation medium 
 
To determine if inhibition of embryo development by L-NAME can be achieved at 
oocytes level, COC were cultured for 24 h in either MPM alone (control) or with L-
NAME at 1 and 10 mM. No significant effect of the inhibitor was obtained when 
oocytes were matured in presence of L-NAME, fertilized and then cultured without the 
inhibitor as indicated by a blastocyst rate of 28 % and 22 % at 0 mM and 10 mM 
respectively. It seemed that the application of the NOS inhibitor had no effect on the 
maturation of oocytes and further embryo development when added at MPM. However 
high arrested rate (81 % and 88 % at 1 and 10 mM respectively) observed in treated 
group compared to 72 % in control, are indicative of impairement of normal 
development (table 4.1). 
 
Table 4.1:  Effects of the addition of L-NAME (0, 1 and 10 mM) to maturation 
medium on development of embryos derived from in vitro system.  
The results are given as mean ± SD  
L-NAME 
concentration 
Number  
oocytes  
Cleavage  
rate (%)    
Blastocyst 
rate (%)    
Arrested  
rate (%)   
0 mM  908 71 ± 11   28 ± 14   72 ± 14  
1 mM  455 63 ± 13   19 ± 15   81 ± 15  
10 mM  605 63 ± 11   22 ± 11   78 ± 11  
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Since high concentration (10 mM) at maturation did not affect either the cleavage or the 
blastocyst rates, the treatment with lowest dose 0.1 mM was omitted. 
 
Experiment 2: L-NAME application in culture medium 
 
To determine whether NO affects preimplantation embryo development, fertilized 
oocytes were cultured in either CR1 medium alone (control) or with L-NAME at 0.1, 1 
and 10 mM level (table 4.2). When one-cell embryos (presumptive zygotes) were 
treated with high concentration (10 mM) L-NAME, the development of most of these 
embryos was significantly affected (p ≤ 0.05) compared to non treated group. Very low 
percentage of embryos developed to blastocyst at 10 mM (1 %) compared to the control 
group (0 mM) with (15 %). L-NAME inhibited normal embryo development past the 
eight-cell stage at 10 mM (data not shown). The inhibitory effect of L-NAME was lost 
when its concentration was decreased to 0.1 or 1 mM (most of embryos developed to 
the blastocyst stage).  The blastocyst rate seemed to be stimulated at 0.1 and 1 mM 
compared to the control: almost two times more blastocyst rate at 1 mM (28 %) 
compared to the control (15 %).  
 
Table 4.2:  Effects of the addition of L-NAME (0, 0.1, 1 and 10 mM) to culture 
medium on development of one-cell embryos in vitro system. The results 
are given as mean ± SD. Values with different superscripts within a 
column differ significantly (p ≤ 0.05) 
L-NAME 
concentration  
Number  
oocytes  
Cleavage  
rate (%)   
Blastocyst 
rate (%)   
Arrested  
rate (%)    
0 mM  640 67 ± 7     15 ± 10a  85 ± 10a    
0.1 mM  218 71 ± 10   22 ± 12a   78 ± 12a    
1 mM  457 68 ± 9    28 ± 18a   72 ± 18a    
10 mM  412 66 ± 6     1 ± 2b     99 ± 2b     
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Experiment 3: L-NAME addition in maturation and culture media 
 
To determine whether embryos that remained unaffected after L-NAME applications in 
MPM were further susceptible or not to nitric oxide reduction, COC were matured in 
presence of L-NAME, fertilized without then culture with. L-NAME inhibited normal 
embryo development (past the eight-cell stage) at 10 mM. The result was similar to the 
inhibitor addition in culture only as shown in table 4.3 with signifcative effect at high 
level: 7 % at 10 mM against 31 % blastocyst rate in not treated group. The blastocyst 
rate seemed to be stimulated at 0.1 and 1 mM compared to the control: from 32 % to 36 
% blastocyst rate at 0.1 and 1 mM respectively compared to 31 % in the control group. 
 
Table 4.3: Effects of the addition of L-NAME (0, 0.1, 1 and 10 mM) to maturation 
and culture media on development of embryos derived from in vitro 
system. The results are given as mean ± SD. Values with different 
superscripts within a column differ significantly (p ≤ 0.05) 
L-NAME 
concentration 
Number 
oocytes  
Cleavage  
rate (%)   
Blastocyst  
rate (%)   
Arrested  
rate (%)   
0 mM  203 63 ± 8    31 ± 6a    69 ± 6a   
0.1 mM  256 59 ± 10  32 ± 4a     68 ± 4a     
1 mM  210 51 ± 12  36 ± 11a   64 ± 11a   
10 mM  215 53 ± 8    7 ± 15b    93 ± 15b  
 
In general the application of the inhibitor had no effect on the cleavage rates either at 
maturation (table 4.1), culture (table 4.2) or both (table 4.3) at any concentration level 
when compared to the control group. A great percentage of oocytes incubated with L-
NAME cleaved regardless of the dose applied in maturation medium: 71 %, 63 % and 
63 % cleavage rates at 0, 1 and 10 mM respectively. A cleavage rate of 67, 71, 68 and 
66 % were obtained at 0, 0.1, 1 and 10 mM L-NAME application in the culture medium 
respectively. These data demonstrated that L-NAME inhibited the embryo development 
after cleavage to blastocyst stages in a concentration-dependent manner at certain 
conditions or stage. 
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** Spermatozoa and NO-inhibitor test 
 
Viability and motility of sperm (2x106/ml) in fertilization medium without oocytes was 
tested after L-NAME addition. At high level (20-50 mM) of L-NAME, sperm cells die 
between 1 and 3 h, the minimum required for the fertilization to begin. At low 
concentration (1-10 mM), after 5 h they still alive and conserve their motility 
comparable to the control.  
Concentration  1h  2h30  5h  24h 
Control  +++  +++   ++  - 
1 mM   +++  +++  ++  - 
10 mM  +++  ++  + slower  death 
20 mM  +++   death 
50 mM  death       
+++ = viable spermatozoa with high motility, ++ = viable spermatozoa with motility,  
+ = viable spermatozoa with low motility, - = viable spermatozoa without motility 
 
Due to the toxicity of L-NAME on the spermatozoa after some hours only as shown on 
the viability and motility, the application of this inhibitor at fertilization was avoided. 
 
4.2 Qualitative identification of endothelial and inducible NOS genes 
 
To determine which of the NOS isoforms are expressed in embryos at different stages 
of preimplantation development, embryonic mRNAs were amplified using RT-PCR. 
Amplification products were identified by agarose gel electrophoresis visualised under 
UV light after confirmation of the sequence. In addition, to determine the specificity of 
changes in eNOS and iNOS expression, RT-PCR for GAPDH was carried out. We 
expected the level of GAPDH, often considered as housekeeping gene, to remain 
constant during embryogenesis. All pooled embryo samples as well as positive controls 
(granulosa cells, follicle and ovary) expressed the highly abundant GAPDH gene. 
Amplification of a 137-bp fragment of the eNOS gene was evident in all pooled oocyte 
and embryo samples at different level of transcript. This was also true for expression of 
a 167-bp fragment of the iNOS gene. The pattern expression of these genes changed 
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through development: eNOS was higher in immature oocyte and lower in mature oocyte 
and 8-cell embryos contrasting with iNOS with remarkable transcript in oocytes, two 
and four cell embryos than further stages (figure 10). Their transcripts were identical 
and highest in the positive controls.  
   Im     MO     2C     4C      8C     Mor     Bl      GC     Fol     Ov      ctr  
eNOS         
iNOS         
GAPDH      
Figure 10: RT-PCR amplification of endothelial and inducible NOS genes from 
cDNA amplified from bovine immature (Im) and mature (MO) oocytes, 
two-cell (2C), four-cell (4C), eight-cell (8C), morulae (Mor) and 
blastocyst (Bl) with the negative control (no template). Granulosa cells 
(GC), follicle (Fol) and ovary (Ov) are indicated as positive control. 
GAPDH amplified as an endogenous control. 
 
4.3 Quantitative expression profile of NOS isoforms in oocytes and embryos 
 
With the aim of studying the quantitative expression profiles of NOS genes in different 
embryonic stages, eNOS, nNOS and iNOS were investigated. Embryonic mRNAs were 
subjected to fluorescence-monitored real-time quantitative PCR using sequence specific 
primers. Since the investigated genes were all expressed at immature oocyte, this stage 
has been selected as a calibrator and its values are set as 1 to present the relative 
abundance of each transcript in the preimplantation development stages after 
normalization with the endogenous control (histone 2a gene). The relative expression 
for each gene was calculated using the relative standard curve method. 
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As illustrated in figures 11, 12 and 13 below, differences in mRNA expression among 
the different embryonic developmental stages were found for eNOS, iNOS and nNOS 
genes.  
 Developmental stage  
Figure 11: The relative distribution of eNOS isoform mRNA expression within 
oocytes and early embryonic developmental stages: immature (IM) and 
mature (MO) oocytes then embryos at two-cell (2C), four-cell (4C), 
eight-cell (8C), morula (Mor) and blastocyst (Bl) stages. Values with 
different letters differ significantly (p ≤ 0.05) 
 
Developmental stage  
Figure 12: The relative distribution of iNOS isoform mRNA expression within 
oocytes and early embryonic developmental stages: immature (IM) and 
mature (MO) oocytes then embryos at two-cell (2C), four-cell (4C), 
eight-cell (8C), morula (Mor) and blastocyst (Bl) stages. Values with 
different letters differ significantly (p ≤ 0.05) 
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The iNOS and eNOS genes were strongly expressed in oocytes, 2-cell and 4-cell 
embryos but were far less prevalent in other developmental stages, except iNOS at 
blastocyst stage. This graph is comparable to typical accumulation transcript from 
maternal followed by progressive degradation after fertilization. The pattern of eNOS 
and iNOS expression was different in relation to oocytes steady state which shows low 
level of expression of both NOS mRNA in mature oocyte compare to immature oocyte 
probably in relation with their role at maturation. Nitric oxide synthase and nitrite 
production in human spermatozoa were evidenced and it was suggested that endogenous 
nitric oxide is beneficial to sperm motility (Lewis et al. 1996, Herrero et al. 2003). The 
significant (p ≤ 0.05) increased transcript at two-cell embryo stage compare to mature 
oocyte may be due to the contribution of NOS from spermatozoa. A significantly 
expression of iNOS was observed at blastocyst compare to earlier stage (eight-cell, 
morulae). 
 Developmental stage  
Figure 13: The relative distribution of nNOS isoform mRNA expression within 
oocytes and early embryonic developmental stages. immature (IM) and 
mature (MO) oocytes then embryos at two-cell (2C), four-cell (4C), 
eight-cell (8C), morula (Mor) and blastocyst (Bl) stages. Values with 
different letters differ significantly (p ≤ 0.05) 
The neuronal NOS gene transcript well expressed in immature oocytes was absent in the 
following stages except at 4-cell and morulae stage. Neuronal NOS from maternal 
origine degraded progressively till the embryonic becomes active at morulae stage. 
 
 
Results   65
4.4 Expression and localization of NOS protein during preimplantation development 
 
As NOS gene expression was detected in unfertilized oocytes and preimplantation 
embryos, immunocytochemistry was used to determine whether NOS proteins are 
expressed in oocytes and embryos. Expression of eNOS and iNOS was detected in 
oocytes and embryos during the preimplantation period as expected (figure 14A). The 
pattern of immunostaining, however, seemed to exhibit slight differences depending on 
the NOS isoform investigated although both are stable throughout this period. 
After omitting each primary antibody, fluorescence was not observed (figure 14A-k and 
B-k) indicating that the staining was specific for each of the NOS proteins. 
In germinal vesicle-stage oocytes (c), iNOS immunoreactivity was localized in the 
germinal vesicle and cytoplasm. In matured oocytes (d) the iNOS staining accumulated 
mostly around the condensed chromosomes as indicated in red color. 
Inducible NOS protein was distributed in fine discret granule uniformly in the 
cytoplasm and around nuclei of oocytes and embryos. The intensity of staining was 
however weaker in the perinuclear areas than the cytoplasm. Embryos at the eight-cell 
(h) and morulae (i) stages exhibited distinct positive zone surrounding the cell 
boundary. Staining was distributed at the periphery of the cytoplasm in zygote (e) and 
throughout the preimplantation period whereas the ICM in blastocyst (j) showed weaker 
labeling for iNOS than the trophectoderm cells. 
Endothelial NOS protein was diffuse throughout the cytoplasm of oocytes to blastocyst 
stages with a weak staining in the nuclei as described by Nishikimi et al. (2001). In 
cumulus oocyte complex (a, b) the unstained zona pellucida delimitates the ooplasm 
from granulosa cells layers whith less eNOS protein than the oocyte which exhibited 
positive granular reaction uniformly distributed throughout the cytoplasm. In germinal 
vesicle-stage oocytes (c), eNOS immunoreactivity was uniformly localized in the 
cytoplasm and germinal vesicle. In matured oocytes (d), the eNOS immunofluorescence 
mostly accumulated around the condensed chromosomes. In embryos eNOS was 
predominantly in the peripherical areas of the cytoplasm and the staining was most 
intensive towards the junctions between blastomeres (2C, 4C, 8C and morulae). The 
staining was apparently more concentrated in the ICM at blastocyst stage than in the 
trophectoderm cells (j). 
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Figure 14: Subcellular localization of eNOS (A) and iNOS (B) proteins in bovine in 
vitro derived oocytes and in preimplantation embryos. Immature (a) and 
mature (b) cumulus oocytes complex, immature (c) and mature (d) 
oocytes then embryos at the zygote (e), two-cell (f), four-cell (g), eight-
cell (h), morula (i) and blastocyst (j) stages were stained by indirect 
immunofluorescence using anti-NOS antibody. Controls (k) were stained 
without anti-NOS antibodies. In red are nucleus stained by propidium 
iodide. Scale bars represent 20 µm. 
 
These predominant granules may represent eNOS in some organelles such as Golgi 
apparatus, mitochondria, endoplasmic reticulum or plasma membrane since this isoform 
is known to be membrane-bound. 
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4.5 Western blot analysis for endothelial NOS 
 
To confirm that NOS was present in the bovine ovary, follicles, granulosa cells and 
oocytes, we performed immunoblots on ovarian, follicular, granulosa and oocytes 
homogenates.  
Western blot analysis revealed the presence of immunoreactive proteins corresponding 
to eNOS (135-kDa) in extracts of bovine ovary and follicles. The amount of eNOS 
protein was similar (independent of the size of the follicle or the tissue-extract 
specificity) in these tissues (Fig. 15) in conformity with the transcript pattern observed 
at RT-PCR. These data support the immunostaining results and show that eNOS protein 
is present in bovine follicle and ovary and by extrapolation eventually in granulosa 
cells, oocytes and embryos (to be studied). 
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5 Discussion  
 
In light of studies focused on NO production and emphasizing its crucial importance 
during the maturation, fertilization and embryogenesis (Manser et al. 2004, Tranguch et 
al. 2003, Nakamura et al. 2002, Nishikimi et al. 2001, Chen et al. 2001, Kuo et al. 2000, 
Jablonka-Shariff and Olson 1998, Lim and Hansel 1998) we investigated the 
participation of the bovine oocytes and preimplantation embryos in NO synthesis and 
development-associated functions. The purpose of this study was to determine whether 
nitric oxide synthases genes were synthesized by bovine oocytes and preimplantation 
embryos in a regulated manner during development.  
In the present work, the role, the identification plus expression profile and the 
localization of NOS (endothelial and inducible isoforms) protein product in oocytes and 
preimplantation embryos of bovine were investigated in vitro system by application of 
NOS inhibitor (L-NAME), PCR, and immunofluorescence staining using antibodies 
against eNOS and iNOS respectively. Our results clearly demonstrate that significant 
level of NO is produced during in vitro development of bovine oocytes and 
preimplantation embryos. 
 
5.1 Inhibitory effects of L-NAME on development of embryos in vitro 
 
These data indicate that bovine embryos cultured in medium containing NO inhibitor, 
from the one-cell to the blastocyst stage, were developmentally affected becoming 
nonviable at high doses (10 mM L-NAME) as compared to the control group (0 mM) or 
their counterparts incubated only in maturation medium. Previous reports in mice and 
rats have shown that embryos cultured in medium containing NOS inhibitors were 
developmentally delayed (Biswas et al. 1998, Gouge et al. 1998, Nishikimi et al. 2001, 
Tranguch et al. 2003, Manser et al. 2004). We believe that the difference of inhibition of 
oocytes and zygote is due to the presence of maternal factors regulating development or 
mitosis. The time that activation of embryonic NOS transcription occurs may explain 
that the treated oocytes did not respond in the same manner as the one-cell embryos. 
Developing in normal medium newly synthesized NO in the absence of L-arginine 
competitor is possible but may be made impaired in presence of excess L-NAME. It is 
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likely that a physiological level of NO is required for oocyte survival and subsequent 
development (Nishikim et al. 2001). Addition of low concentrations of NOS inhibitor 
could reduce the excessively generated NO during development, but NO concentrations 
below the physiologically required amount, due to addition of high concentrations of 
NOS inhibitor, may impair embryo survival. In our study the optimum concentration 
was 1 mM. We have demonstrated indirectly that NO is produced in preimplantation 
embryos and that its production is required for normal embryonic development. The 
results from exogenous effect of pharmacological substances are conflicting. The 
development of mouse embryos beyond the two-cell stage in vitro was completely 
inhibited by L-NAME whereas L-NIO and AG had no effect (Nishikimi et al. 2001). L-
NAME is generally known to have a higher potency in inhibiting eNOS than do L-NIO 
and AG, both relatively selective inhibitors for iNOS (Boer et al. 2000). This difference 
of effect of NOS inhibitors could be explained by the inactivation of both eNOS and 
iNOS or even all three isoforms activities by L-NAME. Probably when iNOS only is 
blocked by L-NIO or AG, other NOS isoforms may supply its action so that embryo 
development is no more or less affected.  Studies on single-NOS knockout mice 
revealed that, reproductive abnormalities exist such as lower ovulatory efficiency, 
compromised erectile function, shorter and less variable estrous cycles, and reduced 
ovulation, atypical oocytes morphology (Jablonka-Shariff et al. (1999b), Tempfer et al. 
(2000), Sengoku et al. (2001)). However, no abnormalities in preimplantation embryo 
development in single knockout mice were seen but double knockout mice loss during 
development has been reported by Tranguch and Huet-Hudson in 2003, although the 
stage at which embryonic loss occurs is not known.  
Oxygen free radical species, including NO, generated intracellularly, are required for 
the progression of embryos through the two-cell stage and probably also for the 
transition between maternal and embryonic gene expression in mouse embryos 
(Nishikimi et al. 2001). Nitric oxide is a labile gas molecule with half-life time of about 
some seconds (< 6 sec)( Thomas et al. 2001). Direct measurement of NO in the context 
of its involvement in cellular signalling is virtually impossible. We rely on the second 
level evidence (NOS or cGMP) to draw conclusions. In many tissues, NO can mediate 
its effects through the cGMP pathway, this may be at least in part, embryos (in mouse) 
as proposed by Chen et al. (2001) and Tranguch et al. (2003) in mouse embryos. 
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Embryo development may be continuously affected by newly synthesized NO during in 
vitro culture (Lim and Hansel 1998) and continuous removal of NO may be beneficial 
to optimize prehatching development as shown here by L-NAME addition. However 
embryos themselves do not appear to produce toxic amounts of NO, as indicated by the 
high cleavage and blastocyst rates in control than the treatment in this study. De novo 
production of the NO metabolites in medium containing L-arginine could not be 
detected after in vitro culture of bovine embryo for periods up to 174 h by Lim and 
Hansel (1998) and murine by Nishikimi et al. (2001). It looks like in unstimulated or 
normal medium embryos do not produce nitrite at detectable amounts.  
We did not assess whether all oocytes were recovered mature by evaluating germinal 
vesicle breakdown and presence of polar bodies. Furthermore, we cannot prove that all 
recovered oocytes were fertilized. Thus, we cannot exclude that oocytes that did not 
develop to two-cell stage or blastocyst stage were not fertilized or immature. This has to 
be kept in mind when interpreting the results of our study.  
An alternative approach to better understand NO stage-specific role could be the 
analysis of mRNA patterns of different isoforms. 
 
5.2 Expression profile of NOS genes  
 
In bovine, not all stages of preimplantation embryos or oocytes showed quantifiable 
mRNA expression for all three NOS genes, contrasting with our qualitative 
identification data or previously reported results in mouse by Tranguch and colleagues 
in 2003. Endothelial and inducible NOS were significantly expressed in oocytes, 2-cell 
and 4-cell embryos. Embryonic gene activation of iNOS was observed at blastocyst. 
Only two embryonic stages (4-cell and morulae) and immature oocyte showed 
measurable nNOS transcripts. This study shows, for the first time, the profile of mRNA 
for all NOS isoforms in preimplantation embryos and in particular in bovine, providing 
further evidence for the importance of NO production in mammalian embryo 
development. Analysis of stage-specific patterns reveals potentially complex 
interactions between these isoforms since they are stage-specific isoform regulated. 
These data attested that not only NO is required for preimplantation embryo 
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development but also multiple NOS isoforms are present to ensure its production at each 
stage except may be at 8-cell.  
Previously in our laboratory using microarray technique, eNOS was revealed 
significantly (p ≤ 0.05) downregulated at blastocyst stage compared to oocyte stage 
(Mamo 2004). At the same time iNOS was differently regulated at these two stages but 
not at significant level. It is known that developmental arrest at the time when 
embryonic gene activation occurs is caused by disturbance of transcriptional activity or 
redox regulation in embryos (Telford et al. 1990). In this case the susceptibilty of 
blastocyst to NO reduction may correspond to the initiation of embryonic genome 
activation of nNOS and iNOS. Before this stage embryos relayed on the maternal 
accumulated mRNA and proteins. Our NOS profiles seemed to confirm the NADPH-
diaphorase staining experiments, which shows two peaks of NOS activity in mouse 
embryos during the preimplantation period (Nishikimi et al. 2001). According to these 
authors the first peak occurred immediately after fertilization (in zygote) then 
maintained consistant in two-cell and the second one at morulae-blastocyst stage. In sea 
urchin eggs, Kuo et al. (2000) found an increase in the activity of NOS after 
fertilization, and reported that NOS and NO-related bioactivities were necessary and 
sufficient for successful egg activation at fertilization. It could be inferred that the role 
of NOS and the related metabolism in egg activation is conserved through evolution 
from sea urchins to mammals. The second NADPH-diaphorase peak is paralleling our 
nNOS and iNOS mRNA content whereas the first peak corresponds to eNOS and iNOS 
activities at (zygote and) two-cell stage (high transcript). In our study mRNA transcript 
in zygote is missing. Moreover, L-NAME decreased NADPH-diaphorase activity at 
two-cell stage; this evidences once more the probable correlation between the NOS 
enzyme and the mRNA status. Taken together, the reduced developmental competence 
or nonviability of embryos could result from their incapability to activate the NO 
production at some critical time. Detectable nitrite generation by bovine macrophages is 
preceded by the induction of iNOS mRNA in liver (Adler et al. 1995). The complexity 
of NOS catalysis, reflected in the diversity of its cofactors and cosubstrates, certainly 
leads to important cell-specific differences in NOS regulatory pathways (Michel and 
Feron 1997). Our result shows that NOS mRNAs decreased in mature oocyte compare 
to immature oocyte partially in accordance with Nakamura and colleagues. In fact, 
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Jablonka-Shariff and Olson, 2000 demonstrated that the eNOS derived NO is a key 
modulator of oocyte meiotic maturation by using L-NAME with whild type in vitro and 
eNOS knock-out oocytes. In contrast Nakamura et al. 2002 proposed that the iNOS-
NO-(cGMP) axis may play an important role in oocyte meiotic maturation. According 
to Nakamura et al. 2002 the lowering of NO is necessary to stimulate GVBD by 
decreasing cGMP.  
The iNOS transcript seems to be constantly expressed in embryos than the supposed 
constitutives ones (nNOS and eNOS). Real-time PCR has proven itself to be valuable 
tool for analysing gene expression at a single embryo level (El-Halawany 2003). The 
variability observed between NOS isoforms (from 7-10 oocytes/embryos) in the 
expression levels can not be attributed to the technique (real-time PCR alone) since high 
reproducibility between identical replicates was prerequisite to validate the results. 
Therefore it could be assumed that the main factor contributing to the observed 
variability are the differences among individuals in each isoform. Moreover the 
potential variation that exists in mRNA expression among genetically heterogenous 
eggs and embryos has been reported by De Sousa et al. (1998c) in bovine.  
More evidence of NOS presence in oocytes and embryos may come from cytochemical 
and immunological studies.  
 
5.3 Expression and localization of eNOS and iNOS during preimplantation development 
 
In this study, oocytes and preimplantation embryos showed immunostaining for 
endothelial and inducible isoforms of NOS proteins in conformity with the qualitative 
identification. Immunocytochemistry studies showed that eNOS and iNOS proteins 
were present in rodents oocytes and embryos as reported in mouse by Gouge et al. 
(1998) and Nishikimi et al. (2001) in contrast to Gagioti et al. (2000) who did not 
evidence these isoforms in mouse delayed blastocyst. The heterogeneous localization of 
eNOS is known to vary depending on the species or degree of confluency of cells 
(Govers et al. 2002). In this study eNOS was predominantly in the peripherical areas of 
the cytoplasm and the staining was most intensive towards the junctions between 
blastomeres (2C, 4C, 8C and morulae). These predominant granules may represent 
eNOS in some organelles such as Golgi apparatus, mitochondria or plasma membrane 
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since this isoform is known to be membrane-bound (Pollock et al. 1993, Jablonka-
Shariff et al. 1998). The mechanisms regulating the intracellular distribution of eNOS 
between the Golgi and plasma membrane pools and the physiological role underlying 
their distinct regulation remain unknown. In germinal vesicle-stage oocytes, NOS 
immunoreactivity was localized diffusely in the cytoplasm and nucleus but was 
accumulated around the condensed chromosomes in mature oocytes. NO is thought to 
react with thiol residues of effector proteins in a diffusion-limited reaction, however the 
greatest amount of NO is in the perinuclear region of cells in localized S-nitrosylation 
reactions (Gow et al. 2002). Moreover NO generated in the Golgi or perinuclear area 
would be more highly concentrated in membranes of the Golgi complex or around the 
nucleus and more apt to produce autocrine actions than NO synthesized in the plasma 
membrane, which may readily diffuse to extracellular targets (Fulton et al. 2004). Our 
results show variations in NOS protein in stage dependent way suggesting NOS-derived 
NO regulation in relation probably with its roles in oocyte meiotic maturation 
(Jablonka-Shariff et al. 2000, Nakamura et al. 2002), trophoblast outgrowth and 
implantation (Gagioti et al. 2000, Navaro et al. 1997, Sengoku et al. 2001). 
Unfortunately, at present, any correlation between the amount and localization of the 
NOS activities and the two NOS isoforms cannot be explained. Inducible NOS is known 
to increase substantially after fertilization in ovulated mouse oocytes and embryos 
(Nishikimi et al. 2001). Nitrate and nitrite, metabolites of NO, were detected in the 
conditioned medium of embryos supplemented with L-arginine by Gouge et al. (1998) 
and Athanassakis et al. (2000) only in presence of toxic stimuli to the embryos, such as 
IFNγ, TNFα and LPS in contrast to Lim and Hansel (1998) in bovine; Nishikimi et al. 
(2001) in murine who could not reveal the presence of these metabolites in medium of 
embryos cultured with or without L-arginine using the Griess assay. Therefore, it can be 
considered that an optimum amount of NO is required for physiological regulation of 
preimplantation development, but lower or higher concentrations of NO generated in 
embryos may play a potential role in early embryonic death. The lack of parallelism 
between iNOS, eNOS proteins and their mRNA may be due to the dissociation between 
transcription and translation as reported by Jablonka-Shariff and Olson (1997). In fact 
they observed that after ovulation, iNOS mRNA decreases, and iNOS protein increases 
in mouse ovary.   
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Another confirmation of NOS protein expression in the bovine ovary, follicles, 
granulosa cells and oocytes, was carried out by immunoblots analysis. Western blot 
analysis revealed the presence of immunoreactive protein corresponding to eNOS (135-
kDa) in ovary and follicles extracts. There was no difference in eNOS protein in these 
tissues in conformity with the transcript pattern observed at RT-PCR. These data 
support the qualitative PCR results and show that eNOS protein is present in bovine 
follicle and ovary and by extrapolation eventually in granulosa cells, oocytes and 
embryos (to be studied). Unfortunately iNOS could not be detected in the same samples. 
Previous reports showed that both eNOS and iNOS localized in mouse oocyte 
(Nishikimi et al. 2001; Mitchell et al. 2004). In swine eNOS was detected in the oocyte 
but not in proliferated cumulus cells (Hattori et al. 2001) contrasting with Grasselli et al. 
(2001) who found the secretion of eNOS in freshly selected granulosa cells but not 
iNOS even after culture with cytokine hTNF-α, a well known iNOS inductor. These 
different results might be due to different surroundings (Hanafy et al. 2001) or different 
animals, and alternatively NO function (which may differ at the oocyte or embryo 
development). The NOS deficiency on ovulatory capacity and early embryonic 
development in mouse is supposed to be modulated by genetic background (Hefler et al. 
2002). They suggested a role for strain-specific modifier genes. The genetic background 
and species specificity should not be neglated since eNOS seems to be more accessible 
in porcine than in rodent. Inducible NOS is mostly evocated in rat and mouse at oocyte 
maturation. Both NOS isoforms may be involved in bovine according to our result.   
 
5.4 Nitric oxide role 
 
Nitric oxide has dual functions in the variety of cell types (Bu et al. 2003): inhibiting or 
stimulating depending on the type of cell, duration or amount of exposure. But the same 
NOS isoform may play entirely distinct biological roles when expressed in different 
tissues, and pathways outlined in one tissue must not necessarily pertain when the same 
isoform is expressed in a different cell (Michel and Feron 1997). The presence of NOS 
protein in cultured oocytes and embryos provided the possibility of studying NO actions 
on embryo development in vitro. Several lines of evidence support multiple roles for 
NO within oocytes and embryos. Until now, no clear role for NO in preimplantation 
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development has emerged, largely due to different culture media and animals being used 
in different studies. However NO has been shown to negatively influence embryo 
development in vitro at high doses from exogenous pharmacological substances like 
SNP, DETA which are NO donors (Barroso et al. 1998, Jablonka-Shariff and Olson 
2000 and Sengoku et al. 2001). Other direct appreciation of NO deprivation is achieved 
by administration of substances derived from L-arginine such as L-NAME, L-NNA, L-
NMMA or AG (Purcell et al. 1999, Chen et al. 2001, Tranguch et al. 2003, Manser et al. 
2004). Manipulation of L-arginine competitors is a standard method of affecting NO 
production, used because direct measurements of NO are technically difficult due to its 
very short half-life (3-5 sec in biological tissue as reported by Thomas et al. 2001).  
As NOS genes role is not yet clear, using microarray eNOS was clustered according to 
its expression pattern with genes involved in cell growth and differentiation whereas 
iNOS was similar to signal transduction activities genes (Mamo 2004). Together with 
i/n-NOS mRNA at morulae and blastocyst, we can hypothezise that NO is involved in 
embryo compaction, cavitation and cell differentiation. NO role during the activation of 
mammalian oocytes is progressively better understood. NOS inhibitors (L-NAME or L-
NNA at 1 mM) suppressed the formation of first polar body of the oocytes in cumulus 
enclosed oocytes in mouse but no effect on germinal vesicle break down was observed 
(Bu et al. 2003). This optimal dose exhibited no effect on oocyte meiotic maturation of 
denuded oocytes. Our results showed no significant effect of L-NAME on cleavage rate 
suggesting that oocyte meiosis may be not affected.  
Different pathways exist (figure 16) between NO-inhibited spontaneous meiotic 
maturation and NO-stimulated meiotic maturation of mouse oocytes (Bu et al. 2004). It 
was suggested that oocytes may release NO from eNOS as a signal for somatic cells to 
steadily suppress the development of cumulus cells (Hattori et al. 2001). Recently, Huo 
et al. (2005) demonstrated that iNOS-derived nitric oxide regulates germinal vesicle 
breakdown and first polar body emission in the mouse oocyte. At the same time, 
exogenous NO from S-nitroso-N-acetylpenicillamine (SNAP) was able to induce 
parthenogenetic activation of pig oocytes matured in vitro (Petr et al. 2005). Moreover 
these authors concluded that NO-dependent activating stimulus seems inadequate 
because it did not induce the exocytosis of cortical granules and also, the cleavage of 
parthenogenetic embryos was very low and embryos did not develop beyond the stage 
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of eight blastomeres. At culture when L-NAME was implemented, we observed a slight 
stimulation of the blastocyst rate at 0.1 and 1 mM doses compare to control whereas at 
the same time 10 mM inhibits bovine embryo development. If intracellular NOS is 
regulated similarly in cultured oocytes and embryos, then embryos with NO deprivation 
could maintain development to control embryos by utilizing intracellular NOS until 
exhaustion. Embryos cultured with L-NAME appeared healthy until 8-cell (data not 
shown), which probably indicates the time taken to reach critically low levels of NO. 
We do not have evidence on the mechanism by which this effect is occurring, but this 
observation warrants further examination. Previous reports found that NO/cAMP/PKA 
and NO/cGMP/PKG might be functional in mouse meiotic maturation (Bu et al. 2003, 
Bu et al. 2004).  
 
Figure 16: The physiological significance of NO in the process of meiotic 
maturation. Before the coming LH surge, the high concentration of NO 
produced by iNOS induces the increase of intrafollicular cGMP and the 
maintaining of meiotic arrest. The incoming of LH surge suppresses 
iNOS expression. The lower concentration of NO induces the decrease of 
intrafollicular cAMP and the meiotic resumption (Bu et al. 2004). 
 
Till now cGMP mechanism is evocated mostly but it seems that other pathways are 
involved to execute the varieties of roles by NO in oocytes and embryos. Another 
possibility is that NO may limit oxygen consumption at the blastocyst stage at the level 
of mitochondrial cytochrome c oxidase (Manser et al. 2004) or act through nitrosylation 
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(Gow et al. 2002). Taken together it is clear that NO contributes to oocyte meiotic 
maturation and early embryo development but is not alone or dominant. Its association 
with PLC-zeta at GVBD or/and fertilization should be considered in calcium 
oscillations sustainance.  
More investigations are needed to better establish the exact role played by each isoform 
at the critical step of embryogenesis beginning from maturation and fertilization. 
 
In conclusion our results demonstrated that addition of NOS inhibitor adversely 
affected bovine embryo development similar to Biswas et al. 1998 in vivo or Lim and 
Hansel (1998) in vitro and confirm that NOS isoforms are present in oocytes and 
embryos as previously reported in murine (Tranguch et al. 2003, Kim et al. 2004). 
Preimplantation embryo may be highly sensitive to alteration of NO levels, and even 
subtle changes of NO levels could interfere with their development. Differences in 
required amount of NO and the sensitivity to cytotoxicity of NO in each developmental 
stages may also suggest that NO/NOS system is tightly regulated in developmental 
stage and isoform specific manner as seen in the profile. In definitive, these results 
demonstrate the importance and relevance of NO, in normal embryo development in 
vitro and the compensatory effect of the different isoform. Experiments in this series 
should be continued using specific inhibitors of NOS, to assess their effects upon 
embryos growth in vitro. Nitric oxide and NOS quantity (protein) are necessary to better 
understand the regulation of these genes. 
 
5.5 Future prospects 
 
Nitric oxide influences on the maturation of cumulus cell-enclosed bovine oocytes has 
to be clearly established in term of NO (metabolites), mRNA and proteins levels in 
immature or mature stages. The temporal characteristics of the NO rise may give us 
clues to its physiological role. These parameters should also be detected in cumulus 
cells to be able to distinguish NO from these cells from oocytes themselves. NO and 
apoptosis need to be clarified at embryonic development by looking closely to genes 
involved in cell apoptosis simultaneously with NOS genes. Apoptosis could be 
examined using a terminal deoxynucleotide-transferase-mediated dUTP-biotin nick end 
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labeling (TUNEL) method to determine whether embryos that arrested were undergoing 
DNA fragmentation. NOS protein details by using the electronic microscopy to specify 
the organells hosting each isoform may be an important approach of prospection. 
Profiling of NOS in in vivo oocytes and embryos should be undertaken to compare the 
transcript of these genes with their counterparts from in vitro since it is proven that 
culture conditions affect mRNA expression.  
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6 Summary 
 
The present study was carried out, (i) to investigate the role of NO in bovine oocytes 
and preimplantation embryos development, (ii) to identify and profile the temporal 
expression pattern of NOS genes in preimplantation developmental stages and (iii) to 
detect and localize the protein products of iNOS and eNOS during this period. 
The investigation of NO role in bovine oocytes and preimplantation embryos 
development was carried out by application of L-NAME, inhibitor of NO production, in 
maturation and culture media. To determine if inhibition of embryo development by L-
NAME can be achieved at oocytes level, COC were cultured for 24h in either 
maturation medium alone (control) or with L-NAME at 1 and 10 mM. The in vitro 
development of bovine embryos was monitored daily to day 2 then at d7 and d9. All 
embryos developed normally through the two-cell stage to blastocyst stage. No 
significant effect of the inhibitor was obtained when oocytes were matured in presence 
of L-NAME as indicated by a blastocyst rate of 28 %, 19 % and 22 % at 0, 1 and 10 
mM respectively. However, high level of arrested blastocyst rates (81 % and 78 % at 1 
and 10 mM respectevely) are indicative of an impairement of normal development. To 
determine whether NO affects preimplantation embryo development, fertilized oocytes 
were cultured in either CR1 medium alone (control) or with L-NAME at 0.1, 1 and 10 
mM. L-NAME inhibited normal embryo development past the eight-cell stage at 10 
mM, significantly (p ≤ 0.05) compare to non treated group. Very low percentage of 
embryos developed to blastocyst at 10 mM (1 %) compared to the control group (15 %).  
The inhibitory effect of L-NAME was reduced when its concentration was decreased to 
0.1 or 1 mM (more embryos developed to the blastocyst stage) with blastocyst rate 
ranging from 15 %, 22 % to 28 % at a level of 0.1, 1 and 10 mM L-NAME respectively. 
Similarly, whether embryos that remained unaffected after L-NAME applications in 
maturation were susceptible or not to NO reduction, COC were matured in presence of 
L-NAME, fertilized without then cultured with NO-inhibitor. L-NAME inhibited 
normal embryo development past the eight-cell stage at 10 mM like in culture. In 
general the application of the inhibitor had no effect on the cleavage rates either at 
maturation, culture or both at any concentration compared to the control group. A great 
percentage of oocytes incubated with L-NAME cleaved regardless of the dose applied: 
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71 %; 63 % and 63 % cleavage rates respectively at 0, 1 and 10 mM were observed in 
maturation medium. During culture the following cleavage rates, 67 %, 71 %, 68 % and 
66 % have been obtained at 0, 0.1, 1 and 10 mM L-NAME, respectively.  
These data demonstrated that L-NAME inhibited the embryo development to blastocyst 
stages in a concentration-dependent manner at certain conditions or stage. 
Before quantifying NOS genes we determine which isoforms are expressed in oocyte 
and embryos at different stages of preimplantation development, by using RT-PCR with 
GAPDH as reference gene. mRNAs have been isolated from ten pooled embryos at 
immature and mature oocytes, 2-cell, 4-cell, 8-cell, or seven morulae and blastocyst, 
then reverse transcribed to cDNAs with random primer. Specific primers have been 
designed from bovine or human NOS sequences using primer express software (version 
2.0, ABI) to amplify different length fragments. These primers have been tested for 
their specificity to produce single specific band in each sample and used for isolation of 
the fragments which were subsequently cloned into plasmid vector. Following dideoxy 
chain termination sequencing, we obtained sequence information on NOS clones using 
BLAST program. Amplification of a 137-bp fragment of the eNOS and 167-bp 
fragment of the iNOS gene were evident in all pooled oocyte and embryo samples and 
also in the positive control. The expression pattern of these genes changed through 
development. To confirm these changes, real-time PCR technology has been used to 
examine the expression level of all three eNOS, iNOS and nNOS genes. The specific 
mRNA transcripts have been examined throughout the different stages of bovine 
preimplantation development. The quantitative reliability of our reaction conditions was 
established by measuring CT values generated from spectrophotometrically quantified 
amounts of plasmid serial dilutions (10 up to 108 copy numbers) which carry isolated 
fragment. The resulting values were used to generate a standard curve to correlate the 
template copy numbers versus CT values. To correct for both mRNA quality and 
quantity, cDNA amount values were adjusted to the reference gene histone 2a. Since the 
investigated genes were all expressed at immature oocyte, this stage has been selected 
as a calibrator, or 1 x and each of the normalized target value was divided by it to 
generate the relative expression levels. The iNOS and eNOS genes were well expressed 
in oocytes, 2-cell and 4-cell embryos but were far less prevalent in other developmental 
stages, except iNOS at blastocyst stage. The pattern of NOS expression was different in 
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relation to oocytes steady state which shows low level of expression of both NOS in 
mature oocyte compare to immature oocyte probably in relation with their role at 
maturation. The significantly (p ≤ 0.05) increased transcript level at two-cell embryo 
stage compare to mature oocyte may be due to the contribution of NOS from 
spermatozoa (Herrero et al. 2003). The absence of quantifiable eNOS/iNOS at 8-cell 
and morulae in contradiction to the qualitative identification is surprising. This could be 
attributed to the determining amount of these genes in the whole embryo. A 
significantly expression of iNOS was observed at blastocyst compare to earlier stages 
(eight cell, morulae). Neuronal NOS transcript well expressed in immature oocytes was 
absent in the further embryonic stages except at 4-cell and morulae stages. 
As NOS expression was detected in unfertilized oocytes and preimplantation embryos, 
immunocytochemistry was used to determine whether NOS proteins are present in 
oocytes and embryos. IVP bovine immature and mature oocytes, zygote, 2-cell, 4-cell, 
8-cell, morulae and blastocyst stages embryos were washed three times in PBS, fixed in 
4 % paraformaldehyde in cytoskeleton buffer overnight at 4 °C. They were 
permeabilized by 1h incubation in 0.5 % Triton-X100 then blocked in 3 % BSA in PBS 
for 1h followed by washing using PBS solution. The specimens were incubated for 1h at 
room temperature with anti-eNOS monoclonal antibody (1:200) and anti-iNOS 
polyclonal antibody (1:80). After three consecutive washes with PBS, oocytes and 
embryos were further incubated for 1h with secondary anti-rabbit IgG FITC conjugated 
antibody (1:500) in dark. In order to visualize the nucleus of the cells, they were finally 
incubated with 0.5µg/ml propidium iodide. Negative controls were processed in the 
same manner but the primary antibodies were omitted. After an ultimate washing with 
PBS, they were mounted on glass slides in Vectashield mounting medium, protected 
with coverslip, sealed with nail polish and examined under laser scanning microscope. 
Expression of eNOS and iNOS was detected in oocytes and embryos as expected, 
however the pattern of immunostaining, seemed to exhibit slight differences depending 
on the NOS isoform. In germinal vesicle-stage oocytes, iNOS immunoreactivity was 
mainly localized in the germinal vesicle and nucleus but after GVBD, the 
immunoreactivity accumulated around the condensed chromosomes. Inducible NOS 
protein was distributed in fine discret granule uniformly in the cytoplasm and around 
nuclei (weaker) of oocytes and embryos. Embryos at the eight-cell and morulae stages 
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exhibited distinct positive zone surrounding the cell boundary. Staining was distributed 
mostly at the periphery of the cytoplasm in zygote and throuought the preimplantation 
period but the ICM showed weak labeling for iNOS than the trophectoderm cells. 
Endothelial NOS protein was diffuse throughout the cytoplasm of oocytes to blastocyst 
stages with a weak staining in the nuclei. In germinal vesicle-stage oocytes, eNOS 
immunoreactivity was mainly localized in the germinal vesicle but after GVBD, the 
staining mostly accumulated around the condensed chromosomes. In embryos eNOS 
was predominantly in the peripherical areas of the cytoplasm and the staining was most 
intensive towards the junctions between blastomeres. These predominant granules may 
represent eNOS in some organelles such as Golgi apparatus, mitochondria, endoplasmic 
reticulum or plasma membrane since this isoform is known membrane-bound. The 
staining was apparently more concentrated in the ICM at blastocyst stage than in the 
trophectoderm cells. 
In conclusion, the current study demonstrated that addition of NOS inhibitor adversely 
affected bovine oocyte maturation or/and embryo development and supports the 
previous finding of the NO role in oocyte and embryogenesis. Moreover, a clear 
difference in the gene expression levels between isoform of in IVP embryos has been 
observed. The exact roles of these genes during meiotic maturation or preimplantation 
development are poorly understood, therefore, analysis of their expression levels could 
be a key step to understand their role during this period. Even real-time PCR has proven 
itself to be valuable tool for analysing gene expression at a single cell scale, not all the 
genes can be validate by methods such as quantitative real time PCR. Therefore, 
combination of more methods is the most suitable way in this kind of work. In 
definitive, these results demonstrate the importance and relevance of NO, in normal 
embryo development in vitro and the compensatory effect of the different isoform. 
Nitric oxide amount and NOS quantity in term of protein are necessary to better 
understand the regulation of these genes. 
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